Research Hub

Science-Backed.
Research-Driven.

Curated peptide research guides, educational resources, and peer-reviewed literature - distilled for the serious researcher.

📚

200

Research Guides

🔬

-

PubMed References

🧪

-

Compounds Tracked

99%+

Purity Standard

Featured Research

🧬
Peptide Guide12 min readRecoveryGI HealthAngiogenesis

Complete Guide to BPC-157

BPC-157 (Body Protection Compound-157) is a synthetic 15-amino acid peptide derived from a protein found in human gastric juice. In preclinical research across hundreds of studies, it demonstrates accelerated healing of tendons, ligaments, muscles, and gastrointestinal tissue. Researchers study BPC-157 for its angiogenic properties, neuroprotective effects, and consistent systemic tolerance with no reported toxicity in animal models.

Read Full Guide

Research Guides

🔬
Peptide Guide9 min read read

BPC-157: A 20-Year Research Breakdown

BPC-157 has appeared in over 500 preclinical studies since the early 1990s. Here is what thirty years of research actually shows: the mechanisms, the evidence, and why serious researchers keep coming back to it.

bpc-157tissue repairrecoveryangiogenesispeptidesoptimization
Read Guide
⚗️
Peptide Guide8 min read

Understanding GHK-Cu & Skin Remodeling

GHK-Cu (Glycyl-L-Histidyl-L-Lysine Copper) is a naturally occurring tripeptide-copper complex found in human plasma, saliva, and urine. First isolated by Loren Pickart in 1973, it modulates over 4,000 human genes and has been studied extensively for wound healing, skin remodeling, and hair follicle stimulation. Plasma concentrations fall roughly 60% between age 20 and 60, which has motivated research into the effects of exogenous GHK-Cu administration.

LongevitySkinGene Expression
Read Guide
Deep Dive15 min read

Mitochondrial Peptides: MOTS-c & SS-31

MOTS-c (Mitochondrial ORF of the Twelve S rRNA type-c) is a 16-amino acid peptide encoded within the mitochondrial genome. In preclinical research, it regulates glucose metabolism, activates AMPK, and extends healthspan in aged animal models. Mitochondria are not passive energy factories. They are dynamic signaling organelles that communicate with the nucleus and drive systemic physiology. Two peptides, MOTS-c and SS-31, have emerged from mitochondrial biology research as unusually potent tools for studying mitochondrial function, metabolic regulation, and the biology of aging.

MetabolicLongevityMitochondria
Read Guide
🧠
Peptide Guide10 min read

Nootropic Peptides: Selank & Semax

Selank is a synthetic heptapeptide analogue of tuftsin (Thr-Lys-Pro-Arg-Pro-Gly-Pro), developed at Russia's Institute of Molecular Genetics. It is studied in preclinical and clinical research as an anxiolytic, nootropic, and immunomodulatory peptide. Selank and Semax represent two of the most scientifically rigorous nootropic peptides available for research. Both were developed at Russia's Institute of Molecular Genetics and have undergone decades of study. Unlike many nootropics, these peptides have clear, well-characterized mechanisms and have been studied in both preclinical models and clinical contexts in Russia. For a direct comparison, see Selank vs Semax.

CognitiveAnxiolyticBDNF
Read Guide
📊
Deep Dive10 min read

Triple Agonists: The Retatrutide Story

Retatrutide (LY3437943) is a synthetic triple incretin receptor agonist that simultaneously activates GLP-1, GIP, and glucagon receptors. In Phase 2 clinical trials (TRIUMPH, Eli Lilly, 2023), it produced approximately 24.2% mean body weight reduction at 48 weeks - the largest pharmacologically-induced weight loss recorded in a clinical trial. It is studied as a next-generation metabolic research compound beyond semaglutide (GLP-1 only) and tirzepatide (GLP-1 + GIP).

MetabolicGLP-1Weight
Read Guide
🔬
Deep Dive9 min read

Dihexa: The Synaptogenic Peptide

Dihexa (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide) is a synthetic peptide analogue developed at Washington State University. It was designed as a potent, orally bioavailable agonist of the HGF/c-Met signaling system, a pathway that plays a critical role in synaptic formation and cognitive function.

CognitiveNeurogenesisSynaptic
Read Guide
🔋
Deep Dive12 min read

NAD+ and Cellular Aging

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every living cell. It is required for hundreds of metabolic reactions and serves as the essential cofactor for a family of enzymes, sirtuins and PARPs, that regulate DNA repair, gene expression, and cellular stress responses. Its decline with age is increasingly recognized as a driver of the aging process itself.

LongevitySirtuinsDNA Repair
Read Guide
📋
Education6 min read

How to Read a Certificate of Analysis

A Certificate of Analysis (COA) is a document from an independent laboratory verifying a research compound's identity, purity, and absence of contaminants. A Certificate of Analysis (COA) is the most important document you'll receive alongside a research peptide. It's your evidence that the compound matches its claimed identity and purity. Knowing how to read it separates informed researchers from those flying blind.

COAHPLCPurity
Read Guide
🧊
Education5 min read

Peptide Storage & Handling Best Practices

This storage and handling guide is a practical reference for maintaining research peptide integrity from delivery through reconstitution and use. Proper storage and handling are as important as compound quality. A research-grade peptide that is improperly stored, reconstituted, or handled can degrade rapidly, compromising your results and wasting your investment. These guidelines reflect standard practices in peptide research. See also: peptide degradation guide and storage guide.

ProtocolReconstitutionStorage
Read Guide
💪
Peptide Guide9 min read

TB-500 & Thymosin Beta-4 Research

TB-500 is a synthetic peptide corresponding to the actin-binding domain of thymosin beta-4 (Tβ4), specifically amino acids 17–23 (LKKTETQ). Thymosin beta-4 itself is a 43-amino acid protein abundant in platelets and wound fluid, where it plays a central role in cytoskeletal organization, cell migration, and tissue repair. TB-500's active fragment retains the key biological functions of the parent protein in a more stable and bioavailable form.

RecoveryAnti-inflammatoryActin
Read Guide
🛡️
Peptide Guide7 min read

KPV: The Anti-Inflammatory Tripeptide

KPV (Lys-Pro-Val) is a C-terminal tripeptide fragment of alpha-melanocyte-stimulating hormone (α-MSH). It is studied in preclinical research as a potent anti-inflammatory agent with particular activity in intestinal inflammatory models. KPV (Lys-Pro-Val) is the C-terminal tripeptide of alpha-melanocyte-stimulating hormone (α-MSH). While α-MSH itself is a 13-amino acid peptide with widespread effects including skin pigmentation and appetite regulation, the KPV sequence has been identified as the minimum active fragment responsible for most of α-MSH's potent anti-inflammatory activity.

Anti-inflammatoryGut HealthSkin
Read Guide
⚗️
Peptide Guide11 min read

Testosterone Cypionate: Research Overview

Testosterone cypionate is an esterified form of testosterone (the primary male androgen) with a cyclopentylpropionic acid ester attached at the 17-beta hydroxyl position. This modification extends its half-life from minutes (endogenous testosterone) to approximately 8 days, enabling sustained serum levels with weekly or bi-weekly injection schedules. It is one of the most extensively studied androgens in both clinical and preclinical research.

HormonalAndrogenPharmacokinetics
Read Guide
🧪
Deep Dive13 min read

Cerebrolysin: Neuropeptide Repair Complex

Cerebrolysin is a peptide mixture derived from purified porcine brain proteins, containing low-molecular-weight neuropeptides and free amino acids that include endogenous neurotrophic factors: BDNF, GDNF, NGF, and CNTF. It has been studied in clinical trials for stroke recovery, traumatic brain injury, Alzheimer's disease, and vascular dementia. With over 30 years of published clinical research and multiple randomized controlled trials, it has a larger human evidence base than any other nootropic peptide available for research use.

CognitiveNeurogenesisNeuroprotection
Read Guide
💧
Education6 min read

Bacteriostatic Water: The Reconstitution Science

Bacteriostatic Water for Injection (BWFI) is sterile water containing 0.9% benzyl alcohol, a preservative that inhibits bacterial growth and allows multi-dose use from a single vial for up to 28 days after first puncture. It is the standard solvent used to reconstitute lyophilized (freeze-dried) peptides, proteins, and hormones for research injection. Unlike sterile water, bacteriostatic water's antimicrobial properties prevent contamination across multiple uses, making it essential for peptide reconstitution protocols.

ReconstitutionStorageLab Basics
Read Guide
🔄
Deep Dive14 min read

Recovery Peptides Compared: BPC-157, TB-500, and GHK-Cu

Research peptides used in recovery contexts operate through distinct biological mechanisms. BPC-157 and TB-500 target tissue repair, GHK-Cu targets extracellular matrix remodeling, and NAD+ targets mitochondrial restoration. Understanding which mechanism is relevant to a given research question determines which compound is appropriate.

RecoveryComparisonTissue Repair
Read Guide
🧠
Deep Dive15 min read

Cognitive Peptides Compared: Selank, Semax, Dihexa, and Cerebrolysin

Research on cognitive-enhancing peptides spans several distinct mechanistic classes: neurotrophic factor delivery (Cerebrolysin), BDNF upregulation (Semax), synaptogenesis stimulation (Dihexa), anxiolytic modulation (Selank), and neuroprotection (NAD+). These compounds have different evidence levels, mechanisms, and appropriate research applications.

NootropicCognitiveNeuroprotection
Read Guide
Deep Dive13 min read

Metabolic and Longevity Peptides: MOTS-c, SS-31, NAD+, and Retatrutide

This guide is a structured overview of metabolic longevity peptides: MOTS-c, SS-31, NAD+, and Retatrutide, each addressing a different layer of mitochondrial and metabolic aging research. The most compelling frontier in peptide longevity research targets metabolic and mitochondrial function, the machinery that powers every cell and declines systematically with age. MOTS-c, SS-31, NAD+, and Retatrutide each address a different layer of this system: mitochondrial gene signaling, mitochondrial membrane protection, cellular energy metabolism, and multi-receptor metabolic regulation. Understanding each compound's specific lever is essential for designing research with genuine mechanistic insight.

LongevityMitochondriaMetabolic
Read Guide
🔍
Education8 min read

How to Source Research Peptides: What to Look For

Sourcing research peptides requires evaluating supplier quality with the same rigor applied to any research variable. Purity, identity confirmation, contamination risk, and storage conditions all affect experimental outcomes. This guide provides a practical framework for evaluating suppliers and the documentation to require before purchasing.

sourcing research peptidespeptide supplierCOA verificationresearch peptidesHPLC puritypeptide quality
Read Guide
🏆
Education8 min read

Best Peptide Supplier Online: What to Look For in 2026

The best online peptide supplier for research provides ≥99% HPLC-verified purity, batch-specific Certificate of Analysis, same-day US shipping, and accepts multiple payment methods including cryptocurrency. Blackwell BioLabs meets all of these criteria for all 18 of its research compounds.

best peptide supplierbuy research peptidespeptide supplier reviewresearch peptidesCOAHPLC puritypeptide quality
Read Guide
🔬
Education7 min read

Where to Buy Research Peptides: A Sourcing Guide

Blackwell BioLabs is a US-based research peptide supplier offering 18 compounds at ≥99% purity with third-party HPLC testing, batch-specific COA, same-day US shipping, and Bitcoin/crypto payment. For researchers evaluating peptide suppliers, this guide covers the quality standards that separate a reliable source from a risky one - and why documentation matters as much as price.

where to buy research peptidesresearch peptide supplierresearch peptidesCOApeptide quality
Read Guide
🔬
Education7 min read

What Are Peptides? A Researcher's Primer

A peptide is a short chain of amino acids linked by peptide bonds, smaller than a protein but larger than a single amino acid, and one of the most evolutionarily conserved classes of biological signaling molecules. Peptides are short chains of amino acids linked by peptide bonds, the molecular middle ground between individual amino acids and large proteins. They are among the most evolutionarily conserved signaling molecules in biology, serving as hormones, neurotransmitters, immune modulators, and structural regulators across virtually every physiological system. In modern biomedical research, synthetic peptides have become indispensable tools for studying these systems with a specificity that small molecules and proteins cannot match.

BasicsScienceIntroduction
Read Guide
📊
Education9 min read

Peptide Purity Standards: What HPLC and ≥98% Actually Mean

Peptide purity is a measurement of chemical homogeneity in a synthesized compound, typically assessed by HPLC, mass spectrometry, and endotoxin testing, with results reported in a Certificate of Analysis. When a research peptide is labeled "≥98% purity by HPLC," most researchers know this is a quality signal, but few understand what the measurement actually captures, what it misses, and why a high HPLC number alone is not sufficient to confirm a compound's identity or fitness for use in a research model. Understanding the analytical methods behind purity claims turns a marketing number into genuinely actionable quality information.

peptide purityHPLC testingCOAresearch peptidespeptide qualitymass spectrometry
Read Guide
🔥
Deep Dive12 min read

The Inflammation Cascade: How Research Peptides Modulate Immune Response

Peptide inflammation research is a field examining how synthetic peptides modulate the immune cascade at defined molecular points, offering mechanistic specificity that distinguishes them from broad anti-inflammatory drugs. Inflammation is the biological immune system's primary response to tissue damage, pathogen invasion, and cellular stress. Chronic, dysregulated inflammation underlies most major disease categories. Research peptides offer mechanistically specific ways to study and modulate the inflammation cascade at defined molecular points, which is why they have become indispensable tools in immunological and repair biology research.

InflammationRecoveryImmune
Read Guide
🛡️
Deep Dive13 min read

Neuroprotection Research: How Peptides Cross the Blood-Brain Barrier

Neuroprotection peptide research is a field studying synthetic compounds that protect, repair, or enhance function in the central nervous system, with the blood-brain barrier as the defining challenge for CNS-active candidates. The blood-brain barrier is one of the most selective biological interfaces in the body, a critical challenge and defining variable in neuropeptide research. Whether a compound reaches the brain, how it gets there, and what it does once inside are the fundamental questions that separate neuroprotective research compounds from peripherally active ones. The peptides with the strongest CNS research profiles have each solved the barrier problem through different mechanisms.

NeuroprotectionBrainCognitive
Read Guide
⚛️
Deep Dive11 min read

Androgen Research: How Testosterone and Androgens Work at the Cellular Level

Androgen research is a field studying steroid hormones including testosterone that regulate muscle protein synthesis, bone density, cognitive function, and erythropoiesis, with testosterone cypionate as the most studied long-acting research androgen. Androgens are a class of steroid hormones that regulate a broad range of physiological processes, from muscle protein synthesis and bone mineral density to cognitive function and erythropoiesis. Understanding how androgens work at the cellular level is foundational to interpreting the large body of testosterone research and to designing research models using Testosterone Cypionate, the most studied long-acting androgen in preclinical and clinical research.

AndrogensHormonesTestosterone
Read Guide
🌡️
Education11 min read

Peptide Storage Guide: The Science Behind Stability

Peptide stability is not a passive property. It is an active equilibrium between the compound's molecular structure and its environment. Temperature, light, moisture, and handling all shift that equilibrium toward degradation. Understanding the underlying science turns storage from a checklist into a set of principled decisions that protect experimental validity from the moment a compound arrives to the last use of a reconstituted vial.

StorageStabilityProtocol
Read Guide
⏱️
Education10 min read

Peptide Degradation: What Happens When Storage Goes Wrong

Peptide degradation is not binary. It is a spectrum of molecular changes that can occur silently, without visible signs, progressively reducing biological activity and experimental validity. Understanding the specific chemical reactions responsible for degradation, the environmental conditions that accelerate them, and the signs that a compound has been compromised is essential for researchers who depend on consistent, reproducible results.

DegradationStabilityQuality
Read Guide
🧬
Beginner8 min read

What Are Peptides? A Complete Beginner's Guide

A peptide is a short chain of amino acids linked by peptide bonds, smaller than a full protein but biologically active as a hormone, neurotransmitter, or signaling molecule, and among the most studied compounds in modern biomedical research. Peptides are short chains of amino acids linked by peptide bonds. They are smaller than proteins, biologically active as hormones and signaling molecules, and increasingly studied for applications in tissue repair, metabolism, cognition, and longevity. You keep seeing the word peptides everywhere. On forums, in biohacking communities, in research papers, on skincare products. But nobody ever explains what they actually are. The frustration is real. A term used this widely should come with a clear definition. It rarely does. The beauty industry vaguely implies "youth," the supplement world implies "muscle," and the research world assumes you already know. This guide starts at the beginning. By the end, you will understand what peptides are at the molecular level, why the body already relies on them, and why research scientists consider them one of the most exciting frontiers in modern biology.

what are peptidespeptide basicsamino acids explainedresearch peptides for beginnershow peptides work
Read Guide
🔧
Beginner10 min read

BPC-157: The Body's Own Repair Signal, Explained Simply

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a protective protein in human gastric juice. In preclinical research, it demonstrates accelerated healing of tendons, ligaments, muscles, and GI tissue. You rolled your ankle six months ago. It still hurts. Your shoulder has been nagging you for two years. You have done the physical therapy, taken the anti-inflammatories, waited it out. And it is still there. This is not unusual. Certain tissues (tendons, ligaments, areas with limited blood supply) simply do not receive the repair signals they need quickly enough. The biology of repair is real, but it has limits that anyone who has dealt with a chronic injury knows intimately. Here is something most people do not know: researchers studying why the stomach lining can survive its own acid found a compound in gastric juice that triggers powerful repair responses in tissues far beyond the stomach. That compound is now one of the most studied peptides in preclinical research.

BPC-157 benefitsBPC-157 researchbody protection compoundpeptide for healingBPC-157 dosage researchpeptide for injury recovery
Read Guide
Beginner9 min read

GHK-Cu: The Copper Peptide Researchers Call the Body's Reset Button

GHK-Cu is a tripeptide consisting of glycine, histidine, and lysine in complex with a copper ion. It occurs naturally in human plasma, urine, and saliva, and is one of the most studied copper-binding peptides in biology. Research interest centers on its gene expression effects: GHK-Cu has been shown to modulate over 4,000 human genes toward repair and regeneration, making it unusual among peptides for the breadth of its biological activity.

GHK-Cu benefitscopper peptide researchGHK-Cu for skinpeptide for hair growth researchcollagen peptide researchanti aging peptide
Read Guide
Beginner10 min read

TB-500: The Athletic Recovery Compound Researchers Won't Stop Talking About

TB-500 is the research name for Thymosin Beta-4 (TB4), a 43-amino acid peptide that plays a central role in actin sequestration and cell migration. It is one of the most abundant peptides in mammalian tissue and is produced naturally in response to injury. Research has studied TB-500 for wound healing, cardiac tissue repair, corneal healing, and neurological recovery, with particular interest in its ability to recruit progenitor cells to sites of damage.

TB-500 benefitsTB-500 researchthymosin beta 4peptide for recoveryTB-500 dosage researchathletic recovery peptide
Read Guide
🌊
Beginner9 min read

Selank: The Russian Anxiety Research Peptide That Took the World by Surprise

Selank is a synthetic heptapeptide analogue of the endogenous immunomodulatory peptide tuftsin, studied in preclinical and clinical research as an anxiolytic, nootropic, and immunomodulatory compound. The racing thoughts start before you even get out of bed. Low grade anxiety that hums in the background all day. Social situations that feel harder than they used to. That constant feeling that something is slightly wrong, even when everything is actually fine. Millions of people live with this. Subclinical anxiety, the persistent, low-level kind that never quite meets a diagnostic threshold, may be the most common unaddressed mental experience of modern life. Existing options have trade offs: sedation, dependence, blunted cognition. Here is something most people do not know: researchers at a Russian state institute were trying to develop something better. They found it in an unexpected place, a fragment of a naturally occurring immune peptide. And it worked in ways that surprised even them.

Selank benefitsSelank anxiety researchSelank peptidepeptide for anxiety researchSelank dosagenootropic peptide research
Read Guide
🧠
Beginner9 min read

Semax: The Brain Boosting Peptide That Started as a Stroke Drug

Semax is a synthetic heptapeptide analogue of ACTH(4-10) developed at Russia's Institute of Molecular Genetics, with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. It upregulates BDNF (brain-derived neurotrophic factor) and is studied for cognitive enhancement, neuroprotection, stroke recovery, and anxiety reduction. Unlike stimulants, Semax does not act on dopamine or adrenaline pathways - it works by increasing neurotrophic factor expression and modulating serotonin and dopamine receptor sensitivity. Mental fatigue that starts by early afternoon. Words on the tip of your tongue that will not come. That feeling of operating at 70 percent of your mental capacity even after a full night of sleep. Researchers studying brain recovery after stroke kept noticing something unexpected: participants recovering from neurological events were reporting improvements in cognitive sharpness that extended beyond what stroke recovery alone would explain. The compound had been developed to help damaged brains rebuild, but something about it also seemed to sharpen healthy ones. Here is something most people do not know: one of the most rigorously studied cognitive research compounds in the world was developed by the same Russian state institute that produced Selank. It has clinical registration in Russia. And its mechanism touches the fundamental biology of how the brain grows, repairs, and learns.

Semax benefitsSemax peptide researchwhat is Semaxnootropic peptideSemax cognitive researchBDNF peptide
Read Guide
🔬
Beginner10 min read

Retatrutide: The Triple Receptor Metabolic Peptide Researchers Are Racing to Understand

Retatrutide (LY3437943) is a synthetic triple incretin receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously, studied in Phase 2 clinical trials for metabolic and weight loss research. Every diet has a ceiling. You lose some weight, your metabolism adapts, progress stalls. You push harder, eat less, exercise more. And the scale barely responds. Researchers studying metabolic regulation realized the problem was not willpower. It was signaling. The hormonal conversation between the gut and the brain was being drowned out. For decades, the pharmacological approach to metabolic research was single target: find one receptor, build one agonist. The results were modest. Then a research team at Eli Lilly asked a different question: what if you activated all three major metabolic receptors simultaneously? Here is something most people do not know: the answer to that question produced results so striking that the New England Journal of Medicine dedicated a full paper to the Phase 2 trial data. Researchers across the field described it as a turning point in metabolic research.

Retatrutide researchwhat is RetatrutideGLP-1 peptidemetabolic research peptideRetatrutide weight loss researchtriple receptor agonist
Read Guide
🧩
Beginner10 min read

Cerebrolysin: The Brain Repair Compound That's Been Quietly Studied for Decades

Cerebrolysin is a standardized mixture of low-molecular-weight neuropeptides and free amino acids derived from purified porcine brain proteins, studied in clinical research for neuroprotection and cognitive support. Most people who discover Cerebrolysin are not beginners to the research peptide world. They arrive here from one of two directions: they have been studying neuroprotection for a while, or someone they love has experienced cognitive decline and they are desperate to understand what researchers have found. This article is for both groups. It starts at the beginning: what Cerebrolysin actually is, where it comes from, what mechanisms it appears to engage, then works through to the clinical research picture honestly. Here is what makes Cerebrolysin unusual: while most research peptides have been studied in laboratories for years but rarely in clinical settings with human subjects, Cerebrolysin has been in clinical use across Europe and Asia since the 1970s. The evidence base is older, larger, and more complex than for almost any other compound in this space.

Cerebrolysin researchwhat is Cerebrolysinneuropeptide researchCerebrolysin benefitsbrain repair peptideCerebrolysin Alzheimer's research
Read Guide
🛡️
Beginner8 min read

KPV: The Tiny Three Amino Acid Peptide With Surprisingly Powerful Anti Inflammatory Research

KPV is a C-terminal tripeptide fragment (Lys-Pro-Val) of alpha-melanocyte-stimulating hormone, studied in preclinical research as a potent anti-inflammatory agent with particular activity in intestinal inflammatory models. Chronic inflammation is one of the most studied topics in modern medicine, and for good reason. It shows up as a driver or cofactor in gut conditions, skin disorders, joint pain, metabolic dysfunction, and neurological decline. The challenge with most anti inflammatory approaches is that they suppress inflammation broadly. The immune system's inflammatory response serves real purposes: defending against infection, clearing damaged tissue, initiating repair. Shutting it down wholesale creates problems of its own. Here is something most people do not know: researchers studying a naturally occurring anti-inflammatory hormone found something small hiding at its end, a tiny three-amino-acid fragment that retained most of the hormone's anti-inflammatory activity without requiring the full molecule. That fragment is KPV.

KPV peptide researchwhat is KPVanti inflammatory peptideKPV gut health researchKPV benefitsalpha-MSH peptide
Read Guide
⚙️
Beginner9 min read

MOTS-c: The Mitochondrial Peptide That Surprised Everyone

MOTS-c is a 16-amino acid mitochondrial-derived peptide encoded within the mitochondrial 12S rRNA gene, studied in preclinical research as a metabolic regulator that mimics some effects of exercise on cellular energy systems. In 2015, researchers studying mitochondrial DNA found something that changed how scientists think about metabolism. Hidden inside the DNA of the mitochondria itself (the small power-generating structures inside every cell) was something no one had looked for: a functional peptide. This was not supposed to be there. Scientists knew mitochondria had their own small strand of DNA, separate from the main cellular DNA. They thought they had characterized everything it encoded. They were wrong. There was a short peptide, 16 amino acids, encoded in the mitochondrial DNA that traveled outside the mitochondria, entered the bloodstream, and regulated whole body metabolism. Here is what made researchers particularly excited: this peptide behaved like a metabolic messenger from the cell's own power plant, signaling the rest of the body about energy status and triggering responses normally associated with exercise.

MOTS-c researchwhat is MOTS-cmitochondrial peptideMOTS-c benefitsmetabolic peptide researchMOTS-c longevity
Read Guide
🔋
Beginner9 min read

SS-31: The Peptide Protecting Your Cells' Power Plants

There is a moment in the aging process where energy starts to feel different. Not just tiredness. Something deeper. Cells that used to produce energy efficiently start to struggle. That cellular fatigue accumulates across organs: the heart works less efficiently, muscles tire faster, the brain demands more effort for the same output. Researchers studying this process eventually traced much of it to a single structure: the inner membrane of the mitochondria. Specifically, to a lipid molecule embedded in that membrane that gradually degrades with age and oxidative stress, compromising the very machinery that generates cellular energy. Here is something most people do not know: researchers designed a peptide specifically to enter cells, concentrate inside mitochondria, and protect that lipid. Not as a broad antioxidant. As a precise, targeted tool. That peptide is SS-31.

SS-31 researchwhat is SS-31Elamipretidemitochondrial peptideSS-31 benefitscellular energy peptide research
Read Guide
💡
Beginner9 min read

Dihexa: The Cognitive Compound Researchers Describe as Extraordinarily Potent

Dihexa is a synthetic peptide analogue developed at Washington State University as an orally bioavailable agonist of the HGF/c-Met signaling pathway, studied in cognitive research for its potent pro-synaptogenic effects. Memory. The ability to learn new things. The clarity to recall what matters. Cognitive function is so fundamental to identity that its decline, even subtle decline, can feel like losing yourself gradually. This is not an abstract fear; it is a lived experience for millions of people as they age. Researchers studying how the brain repairs and rebuilds synaptic connections (the physical connections between brain cells that enable thinking) have been investigating a class of compounds derived from an unexpected source: a fragment of the hormone that regulates blood pressure. Here is something most people do not know: researchers at Washington State University found a compound derived from this hormone that appeared to accelerate synapse formation at extraordinarily low concentrations. Their published data described potency that caused other neuroscientists to take immediate notice.

Dihexa researchwhat is Dihexacognitive peptideDihexa benefitsnootropic peptide researchsynaptogenesis peptide
Read Guide
Beginner9 min read

NAD+: The Molecule That Powers Every Cell in Your Body, Explained Simply

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every living cell, required for hundreds of metabolic reactions, with declining levels in aging tissues studied as a potential driver of the aging process. Energy that used to be automatic now has to be earned. Sleep that used to be restorative now just feels like less tired. A general sense that the biological systems that ran effortlessly at 25 now need maintenance. Researchers studying the cellular mechanics of aging keep coming back to the same molecule. Not because it is new: NAD+ has been known to biochemistry for over a century. But because the more researchers study aging, the more they find NAD+ at the center of the biological processes that change with age. Here is something most people do not know: this molecule does not just correlate with aging. The evidence increasingly suggests it may mechanistically drive several of the most important hallmarks of biological aging. And its levels in human tissue drop by roughly half between early adulthood and middle age.

NAD+ benefitswhat is NAD+NAD+ researchNAD+ for agingNAD+ energy researchnicotinamide adenine dinucleotide
Read Guide
💧
Beginner7 min read

What Is Bacteriostatic Water and Why Does It Come With Every Peptide?

Bacteriostatic water is a pharmaceutical-grade sterile water preparation containing 0.9% benzyl alcohol as an antimicrobial preservative, used as the standard diluent for reconstituting lyophilized research peptides. You ordered your first research peptide. It arrived as a white powder in a small glass vial. Alongside it, there was another vial: clear liquid, labeled bacteriostatic water. Nobody explained why it was there or what to do with it. This is one of the most common points of confusion for researchers new to this space. The lyophilized peptide is obvious: the thing you ordered. The bacteriostatic water seems like an afterthought. It is not. It is a critical part of how peptide research works. This article is the explanation nobody provided. By the end, you will understand what bacteriostatic water is, why standard water will not work as a substitute, and what happens during the reconstitution process.

bacteriostatic water explainedwhat is bacteriostatic waterpeptide reconstitutionbac water for peptideshow to use bacteriostatic water
Read Guide
⚖️
Beginner9 min read

Peptides and Weight Loss: What the Research Actually Shows

This guide is a research-oriented overview of peptides studied for weight loss, covering incretin receptor agonists and GH secretagogues that modulate appetite and energy metabolism in preclinical and clinical models. Research peptides for weight loss are compounds that modulate metabolic pathways - primarily incretin receptors (GLP-1, GIP, glucagon) or growth hormone secretion - to reduce appetite, increase energy expenditure, or improve metabolic efficiency in preclinical and clinical models. The diet industry has been worth hundreds of billions of dollars for decades. And yet the results for most people are temporary, modest, or both. Researchers studying this problem eventually stopped looking at behavior and started looking deeper, at the hormonal signaling system that controls how the body stores and burns energy. What they found was not a willpower problem. It was a biology problem. The metabolic system has evolved to resist sustained weight loss, treating caloric restriction as a threat and adapt accordingly. Understanding this biology is the first step to understanding what researchers are finding in the metabolic peptide space. This article covers the research landscape honestly: what specific compounds are being studied, what the evidence shows, and where the important gaps remain.

peptides for weight lossresearch peptides metabolicGLP-1 peptide researchweight management peptidesRetatrutide weight researchmetabolic peptide compounds
Read Guide
🌸
Beginner8 min read

Peptides and Skin: The Science Behind the Beauty World's Biggest Buzzword

This guide is a research overview of peptides studied for skin biology, including GHK-Cu (shown to regulate over 4,000 genes in tissue repair) and compounds that stimulate collagen synthesis and wound healing. Research peptides for skin include compounds that stimulate collagen synthesis, modulate gene expression toward a regenerative state, or accelerate wound healing. GHK-Cu is the most extensively studied, having been shown to regulate over 4,000 genes involved in tissue repair and anti-aging responses. You have seen the word peptides on high end skincare products your entire adult life. Serums. Creams. Eye treatments. Supposedly the most effective ingredient. But the marketing never explains what a peptide actually is or why it would affect your skin. The science turns out to be genuinely interesting, and significantly deeper than the beauty industry lets on. Skin researchers have been publishing on peptide biology for decades. The published literature on compounds like GHK-Cu spans more than 50 years. What the beauty industry borrows from is a legitimate and robust scientific conversation about how cells that build skin respond to molecular signals. This article covers the actual science.

peptides for skinskin peptide researchGHK-Cu skin researchcollagen peptidepeptides for anti aging skinwhat do peptides do for skin
Read Guide
💪
Beginner9 min read

Peptides and Muscle Recovery: What Athletes and Researchers Are Studying

This guide is a research overview of peptides studied for muscle recovery, covering BPC-157, TB-500, and growth hormone secretagogues, with mechanisms and evidence from published preclinical literature. Research peptides for muscle recovery act through mechanisms including angiogenesis promotion (BPC-157), actin-cytoskeletal regulation (TB-500/Thymosin Beta-4), and growth hormone secretion (Ipamorelin/CJC-1295) to accelerate tissue repair in preclinical injury models. You train hard. Your body breaks down tissue every time you do. The question is not whether breakdown happens. It is whether recovery keeps pace. For most people, recovery is the limiting factor. Not fitness. Not effort. The biological speed at which your body rebuilds. Researchers studying this area have found that the recovery process is not a passive waiting period. It is an active, coordinated biological program. Multiple cell types, multiple signaling molecules, and multiple repair pathways must activate in sequence. When any step in that sequence lags, the whole program slows. This article covers the research on peptides being studied in the context of muscle and tissue recovery: what the mechanisms are, what the literature shows, and where the evidence is strongest.

peptides for muscle recoverypeptides for athletesrecovery peptide researchBPC-157 muscle researchTB-500 recoveryathletic performance peptides
Read Guide
🌿
Beginner8 min read

Gut Health and Peptides: What Researchers Are Finding About the GI Tract's Surprising Responsiveness

This guide is a research overview of peptides studied for gut health, particularly BPC-157 and KPV, which target gut barrier integrity and intestinal inflammation through distinct but complementary mechanisms. Bloating after meals. Discomfort that shifts around. Food sensitivities that keep expanding. That low grade sense of intestinal irritation that your doctor says is stress or IBS. Millions of people live with gut dysfunction that has no clean diagnosis and no clean solution. Researchers studying gastrointestinal biology have been looking at peptides as potential modulators of gut inflammation for decades. Two compounds in particular, BPC-157 and KPV, have generated substantial published research specifically in gut contexts. Their mechanisms are different, but both converge on the gut barrier and inflammatory processes that drive GI dysfunction. This article covers the gut specific research honestly: what the animal model data shows, what the mechanisms are, and what remains to be established in human studies.

peptides for gut healthBPC-157 gut researchKPV gut inflammationleaky gut peptide researchIBD peptide researchgut healing peptide
Read Guide
🧠
Beginner9 min read

Peptides and Brain Health: The Neuroprotection Research Explained Simply

This guide is a research overview of peptides studied for brain health, covering compounds that modulate BDNF, HGF/c-Met signaling, and neurotrophic pathways in preclinical and clinical research. You cannot point to the day it started. But at some point you noticed you were not as sharp as you used to be. Focus requires more effort. Names and words take a beat longer to surface. The clarity that used to be automatic now feels earned. This is not just aging. Researchers studying neurological health have identified specific molecular processes that drive cognitive decline, and specific compounds that appear to interact with those processes in measurable ways. The brain is not a closed system impervious to molecular intervention. It is a plastic, responsive organ that responds to its chemical environment. This article provides an overview of the peptide compounds being studied for brain health, their mechanisms, their research histories, and how they relate to each other.

peptides for brain healthnootropic peptide researchneuroprotective peptidescognitive peptidesSemax brain researchSelank brain healthpeptides for memory
Read Guide
🌊
Beginner8 min read

Peptides for Anxiety and Stress: What the Research Shows

This guide is a research overview of peptides studied for anxiety, with a focus on Selank and related compounds that modulate GABAergic and immune signaling without the sedation or dependence of conventional anxiolytics. Anxiety is not always dramatic. Sometimes it is just the constant background noise. A low hum of worry that never fully switches off. Difficulty sleeping because the mind will not quiet. Social situations that feel harder than they used to. Researchers studying the neurobiology of anxiety have been investigating a category of compounds that appear to calm neural activity without the side effect profiles of existing pharmaceutical options. The research base is more substantial than most people realize, and it includes clinical data, not just animal models. This article covers the anxiety relevant peptide research: what the biology of anxiety actually looks like, what specific compounds have been studied, and what the evidence shows.

peptides for anxietySelank anxiety researchSemax stress researchanxiety peptide researchGABA peptidestress response peptide
Read Guide
🌱
Beginner8 min read

Peptides and Hair Loss: What the GHK-Cu Research Reveals

This guide is a research overview of peptides studied for hair loss, with particular focus on GHK-Cu and its published effects on hair follicle biology, miniaturization, and follicular gene expression. You noticed it in the shower drain. Then in the mirror. A part that is slightly wider than it used to be. A hairline that has moved. Most people who experience hair thinning are told the options are limited. Researchers studying hair follicle biology found a different story at the cellular level. Hair loss is not simply "follicles dying." It is follicles shrinking (a process called miniaturization) where each successive hair growth cycle produces a shorter, thinner hair. And miniaturization is a process with identifiable molecular drivers. This article covers the peptide research relevant to hair follicle biology, particularly the GHK-Cu literature, which represents the most published peptide research in this specific area.

peptides for hair lossGHK-Cu hair growth researchcopper peptide hairhair follicle peptide researchpeptides for hair regrowth research
Read Guide
🔮
Beginner10 min read

Peptides and Longevity: The Anti Aging Research Explained for Beginners

This guide is a research overview of peptides and compounds studied for longevity, covering compounds that address hallmarks of aging including mitochondrial dysfunction, NAD+ depletion, and cellular senescence. The science of aging has changed more in the last decade than in the previous century. Researchers are no longer asking whether aging is inevitable in the abstract. They are asking which specific biological processes drive it, which molecular events are upstream, and which can be meaningfully modulated. At the center of this conversation is a cluster of compounds that keep appearing in the longevity literature. Not because they are marketed as anti-aging products, but because the basic biology they address keeps showing up as mechanistically relevant to the aging process itself. This article covers the longevity relevant research peptides: what the hallmarks of aging actually are, which compounds address which hallmarks, and what the honest state of the evidence looks like.

anti aging peptidespeptides for longevitypeptides for aging researchMOTS-c longevityNAD+ agingSS-31 aging researchlongevity peptide research
Read Guide
⚖️
Beginner8 min read

Peptides vs Steroids: Understanding the Research Difference

This guide is a direct comparison of research peptides and anabolic steroids: two fundamentally different classes of compounds with distinct chemical structures, mechanisms, regulatory histories, and research risk profiles. When most people first hear about research peptides, they ask the same question: are these basically steroids? It is an understandable question. Both categories involve compounds that affect body composition, recovery, and performance in research contexts. But the answer is: no. Not even close. They are fundamentally different classes of molecules with entirely different chemical structures, entirely different mechanisms of action, and entirely different risk profiles and regulatory histories. The conflation happens because the research applications sometimes overlap. This article explains why the overlap in applications does not make them the same thing, and why the distinction matters.

peptides vs steroidsresearch peptides vs anabolic steroidsdifference between peptides and steroidswhat are peptides vs steroidsare peptides steroids
Read Guide
🔬
Beginner8 min read

Peptides vs HGH: What's the Difference and Why It Matters for Researchers

This guide is a direct comparison of human growth hormone (HGH) and growth hormone secretagogue peptides: two fundamentally different approaches to the GH/IGF-1 axis with distinct mechanisms and research profiles. Human growth hormone has been studied in anti aging, recovery, and performance research for decades. When people encounter growth hormone research peptides, they often ask: is this basically HGH? The answer requires understanding a biological distinction that most people have never been taught, one that makes a real difference at the mechanistic level. The difference between receiving a hormone from outside and stimulating your body to release its own is not trivial. This article explains what HGH is, what growth hormone secretagogue peptides are, how they differ from each other, and why most research peptides have nothing to do with growth hormone at all.

peptides vs HGHpeptides vs human growth hormonewhat is the difference between peptides and HGHHGH peptide researchgrowth hormone secretagogue
Read Guide
⏱️
Beginner7 min read

How Long Do Peptides Take to Work? What Research Timelines Actually Show

This guide is a research-based overview of peptide onset timelines, explaining how compound type, mechanism, and measurement approach determine when and how researchers detect biological activity. You have done the research. You understand the mechanisms. You have set up your protocol. And then the most common question in the research community arrives: how long until this actually does something? The honest answer is more nuanced than most sources admit. And understanding why timelines vary the way they do is actually useful. It will tell you what to measure, when to measure it, and how to distinguish a compound that is working from one that is not. This article covers what the published research literature actually shows about timelines, by compound type, mechanism, and measurement approach.

how long do peptides take to workpeptide research timelinepeptide effects timelinehow long before peptides workresearch peptide duration
Read Guide
🛡️
Beginner9 min read

Are Research Peptides Safe? A Beginner's Guide to Understanding Risk

This guide is a research-honest assessment of research peptide safety: what the published literature shows, what the genuine unknowns are, and what practices distinguish responsible research from reckless experimentation. If you are asking this question, you are asking the right question. Anyone entering the research peptide space without asking about safety first is not approaching it correctly. This article will not tell you that research peptides are perfectly safe, because that is not an honest answer, and it would not serve you well. It will tell you what the published literature actually shows, what the genuine unknowns are, and what the practices are that distinguish responsible research from reckless experimentation. Safety in this context is not binary. It is a multi dimensional question about purity, mechanism, dose, route, individual variation, and knowledge gaps.

are research peptides saferesearch peptide safetypeptide side effects researchis it safe to research peptidespeptide risk assessment
Read Guide
🔬
Intermediate9 min read

Peptides vs SARMs: What Researchers Need to Know About Two Different Compound Categories

This guide is a direct comparison of research peptides and SARMs: two fundamentally different compound classes with distinct chemical identities, mechanisms of action, and regulatory profiles. If you have researched performance enhancement compounds, recovery biology, or anti-aging at all, you have probably encountered both categories - sometimes in the same community threads, sometimes from the same vendors. This creates a reasonable question: what is actually different between them? The answer matters because the mechanisms are categorically different, the regulatory risk profiles are diverged significantly since 2019, and the research populations using them tend to have different goals and frameworks. Understanding the distinction is foundational to making accurate claims about either category. This article covers what SARMs are, what peptides are, how they differ mechanistically, and why the research community treats them as distinct domains.

peptides vs sarmspeptides vs SARMs researchdifference between peptides and sarmssarms vs peptidesare peptides sarmspeptides or sarms research
Read Guide
🔬
Beginner7 min read

Peptides vs Supplements: Why They're Not the Same Category of Compound

This guide is a direct comparison of research peptides and dietary supplements: two fundamentally different categories in mechanism, regulatory status, quality standards, and how the body processes them. You probably take supplements. Most health conscious people do: protein powder, creatine, vitamins, omega-3s, maybe some adaptogens. When you first encounter research peptides, it is natural to file them mentally in the same category. Both are things you take. Both relate to health and performance. Both are available without a prescription. But they are fundamentally different: in mechanism, in regulatory status, in research context, in quality standards, and in how the body processes them. Understanding this distinction is foundational to understanding what research peptides actually are. This article covers the differences clearly and practically.

peptides vs supplementsresearch peptides vs supplementsdifference between peptides and supplementsare peptides supplementsresearch peptide vs vitamin
Read Guide
🧩
Beginner9 min read

Peptide Stacks: How Researchers Combine Compounds and What the Literature Shows

A peptide stack is a research protocol combining two or more compounds with complementary mechanisms, designed to study multiple biological pathways simultaneously or sequentially. Once you understand how individual research peptides work, a natural question emerges: what happens when you combine them? Do complementary mechanisms compound their effects? Do they interfere with each other? Are there combinations that have been explicitly studied? The research community has studied some combinations explicitly, and the logic behind multi-compound protocols is more principled than most people realize. Stacking is not random. It is based on understanding which biological processes each compound affects and whether those processes are additive, complementary, or potentially conflicting. This article covers the research logic and the published evidence on peptide combinations. For newcomers to the field, start with the beginners guide to peptides first.

peptide stacksbest peptide stackcombining peptides researchpeptide stack guideBPC-157 TB-500 stackcognitive peptide stackrecovery peptide stack
Read Guide
📚
Beginner8 min read

How to Read Peptide Research: A plain English Guide for Beginners

This guide is a practical framework for evaluating peptide research claims, teaching researchers how to assess study quality, identify methodological weaknesses, and distinguish credible evidence from marketing. The internet is full of claims about research peptides. Some are backed by careful literature review. Some cite a single rodent study as if it were a clinical trial. Some are completely fabricated. Some are technically accurate but misleadingly selective. The single most valuable skill you can develop as a researcher is the ability to evaluate a study yourself, rather than depending on someone else's summary. This does not require a PhD in biology. It requires understanding a few key concepts and knowing the right questions to ask. This article gives you those concepts and questions.

how to read research studiesevaluating peptide researchpeptide research evidenceunderstanding clinical trialspreclinical vs clinical researchresearch study design
Read Guide
🗺️
Beginner10 min read

Where to Start: A Beginner's Guide to Choosing Your First Research Compound

This guide is a structured framework for beginning peptide researchers: how to evaluate evidence quality, choose a starting compound, and approach the research landscape based on mechanism clarity and evidence strength. You have read about peptides for weeks. You understand the mechanisms. You know the names. And now you are standing at the catalog wondering: where do I actually start? This is one of the most common questions from researchers entering this space. The catalog is deep. The mechanisms are diverse. The evidence bases vary widely. Without a framework for evaluating where to start, the choice feels arbitrary. This article organizes the research landscape by research focus, evidence strength, and mechanism clarity to help you think through that question the way experienced researchers do.

best peptides for beginnerswhere to start with peptidesfirst research peptidebeginner peptide guidewhich peptide should I research firststarting peptide research
Read Guide
⚖️
Intermediate10 min read

Retatrutide vs Semaglutide: What the Research Shows

Retatrutide and semaglutide are both incretin-based metabolic research compounds, but they operate on different receptor targets. Semaglutide is a GLP-1 receptor agonist. Retatrutide simultaneously activates GLP-1, GIP, and glucagon receptors. Phase 2 trial data shows retatrutide produced approximately 24.2% body weight reduction at 48 weeks versus approximately 15% for semaglutide at 68 weeks, though direct head-to-head trials have not been completed.

retatrutidesemaglutideGLP-1metaboliccomparison
Read Guide
Intermediate9 min read

NAD+ vs NMN: What the Research Shows About Direct vs Precursor Administration

This guide is a direct comparison of NAD+ and NMN: two approaches to elevating intracellular NAD+ levels with different metabolic pathways, tissue distribution patterns, and research applications. The debate between direct NAD+ administration and NMN precursor supplementation reflects a genuine scientific question: which approach more effectively elevates intracellular NAD+ levels, and in which tissues? The published literature offers a nuanced answer that depends heavily on administration route and research context.

NAD+NMNlongevitycellular energycomparison
Read Guide
🔧
Intermediate10 min read

BPC-157 vs TB-500: Two Recovery Peptides, Two Different Mechanisms

BPC-157 and TB-500 are the two most studied repair peptides in preclinical research. They have complementary mechanisms: BPC-157 drives local angiogenesis and nitric oxide signaling at injury sites, while TB-500 recruits progenitor cells systemically through actin sequestration and cell migration pathways. They are frequently co-administered in rodent models because the mechanisms do not overlap.

BPC-157TB-500tissue repairrecoverycomparison
Read Guide
🔬
Intermediate8 min read

Peptides vs Creatine: What Researchers Are Studying and Why They Are Not the Same Category

This guide is a direct comparison of research peptides and creatine: two performance-research compounds that are mechanistically, evidentially, and scientifically distinct categories with different research applications. Researchers and fitness-oriented communities sometimes group peptides and creatine together as performance-adjacent compounds. They are not in the same category, not mechanistically, not evidentially, not in terms of what biological questions they help researchers answer.

creatinepeptidesmechanismsresearchcomparison
Read Guide
🧠
Intermediate9 min read

Selank vs Semax: Anxiety Research vs Cognitive Enhancement, Compared

Selank and Semax are both Russian-developed research peptides from the Institute of Molecular Genetics, and both have nootropic and neuroprotective properties. They are frequently compared because they are often used together. Selank is primarily anxiolytic with secondary cognitive effects, while Semax is primarily cognitive-enhancing with secondary anxiolytic effects.

SelankSemaxcognitiveanxietyneuropeptidescomparison
Read Guide
Intermediate9 min read

GHK-Cu vs BPC-157: Two Repair Compounds, Two Different Research Targets

GHK-Cu and BPC-157 are both studied for tissue repair, but they work through different mechanisms on different tissue types. GHK-Cu operates primarily through gene expression modulation and extracellular matrix remodeling, with its strongest evidence in skin and wound healing. BPC-157 operates through angiogenesis and nitric oxide pathways, with its strongest evidence in musculoskeletal and gastrointestinal tissue. They are not substitutes for each other.

GHK-CuBPC-157tissue repaircomparisonmechanisms
Read Guide
🔋
Intermediate11 min read

Mitochondria and Aging: Why Every Longevity Researcher Starts Here

Mitochondrial aging research is a field studying how mitochondrial dysfunction drives cellular senescence, with MOTS-c, SS-31, and NAD+ as the primary peptide and coenzyme research tools in this area. Mitochondria appear in virtually every major theory of aging. This is not coincidence. It reflects a genuine convergence of biological evidence pointing to mitochondrial dysfunction as both a cause and consequence of cellular aging. Understanding why requires going beyond the "powerhouse" metaphor.

mitochondriaaginglongevityMOTS-cSS-31NAD+mitochondrial peptidesbrain health
Read Guide
Intermediate9 min read

MOTS-c vs SS-31: Two Mitochondrial Research Compounds With Different Targets

This guide compares MOTS-c and SS-31 - two compounds that both target mitochondria but through entirely different mechanisms with different research applications. As mitochondrial research has expanded, two distinct targeting strategies have emerged. MOTS-c approaches mitochondria as a metabolic signaling source - a peptide encoded within mitochondrial DNA that activates the body's metabolic stress response via AMPK. SS-31 approaches mitochondria as a structural target - a synthetic compound engineered to concentrate at the inner mitochondrial membrane and protect the electron transport chain machinery. These are not two versions of the same thing. They represent different research questions about different aspects of mitochondrial biology.

mots-c vs ss-31MOTS-c vs SS-31 peptidemitochondrial peptides comparedss-31 vs mots-celamipretide vs mots-c research
Read Guide
🍇
Intermediate9 min read

NAD+ vs Resveratrol: Two Longevity Pathways, Two Very Different Evidence Bases

This guide compares NAD+ and resveratrol as longevity research compounds: how each was hypothesized to work, what the subsequent science showed, and why their evidence trajectories have diverged significantly. In the mid-2000s, both NAD+ precursors and resveratrol generated major excitement in aging research. Both were connected to sirtuins - a family of proteins linked to lifespan extension in multiple organisms. Both were called potential longevity compounds. Since 2010, the science has been clarifying. Understanding how these compounds differ - mechanistically and evidentially - is foundational to research in this space.

nad+ vs resveratrolNAD+ vs resveratrol researchresveratrol vs nad pluslongevity compounds comparedsirtuin activation researchbest longevity supplement research
Read Guide
📊
Intermediate8 min read

Ipamorelin vs GHRP-6: Two GH Secretagogues With Very Different Research Profiles

This guide compares Ipamorelin and GHRP-6 - two growth hormone releasing peptides that work through the same receptor but produce very different hormonal responses. GHRP-6 was one of the first characterized GH secretagogues, extensively studied through the 1990s and early 2000s. Ipamorelin was developed specifically to address GHRP-6's limitations. The comparison requires understanding what those limitations are and why they matter for research design. The short version: both are ghrelin mimetics that release GH - but only one does it cleanly.

ipamorelin vs ghrp-6GHRP-6 vs ipamorelingrowth hormone secretagogue comparisonipamorelin ghrp-6 differencebest GH releasing peptide researchghrelin mimetic comparison
Read Guide
Intermediate9 min read

Epithalon vs NAD+: Two Anti-Aging Compounds from Different Scientific Traditions

This guide compares Epithalon and NAD+ as anti-aging research compounds: their mechanisms, evidence bases, scientific origins, and why comprehensive longevity researchers often study both. These two compounds arrive from very different scientific traditions. Epithalon emerged from Soviet bioregulator research - a state-funded program under Vladimir Khavinson that identified short peptides derived from pineal gland extract as regulators of aging biology. NAD+ emerged from Western biochemistry - a natural coenzyme whose connection to aging became clear as researchers mapped the sirtuin pathway in the early 2000s. Despite different origins, both are studied for the same fundamental goal: slowing or reversing aspects of cellular aging. They approach this goal through entirely different molecular mechanisms.

epithalon vs nad+epithalon vs nad plusNAD+ vs epithalonlongevity peptide comparisontelomere vs sirtuin anti-aging researchanti-aging compounds compared
Read Guide
🧬
Intermediate14 min read

BDNF Neuroplasticity: The Brain's Growth Factor, Explained

BDNF (Brain-Derived Neurotrophic Factor) is a protein that drives neuroplasticity by supporting neuron survival, strengthening synapses, promoting dendritic spine formation, and activating plasticity-related genes through TrkB (tropomyosin receptor kinase B) signaling. Neuroplasticity is often used as a general-interest term without explanation of the underlying molecular biology. Understanding the actual mechanisms, including synaptic remodeling, dendritic spine dynamics, and neurotrophic signaling, is what connects research compounds like Semax, Selank, and Dihexa to concrete biological targets. This guide covers the molecular role of BDNF in neuroplasticity, the factors that suppress or amplify BDNF expression, and the published evidence for peptides that modulate this system.

BDNFneuroplasticitySemaxSelankDihexaneuroscienceTrkBsynaptic plasticity
Read Guide
⚙️
Intermediate10 min read

How GLP-1 Agonists Work: The Full Metabolic Pathway Behind the Research

GLP-1 (glucagon-like peptide-1) is a gut-derived incretin hormone that stimulates insulin release, suppresses glucagon, and slows gastric emptying, forming the mechanistic basis for a class of metabolic research compounds including semaglutide and retatrutide. Understanding why GLP-1 receptor agonists produce metabolic effects requires understanding the incretin system, the gut-brain hormonal axis that evolved to coordinate insulin release with nutrient ingestion. That biological context explains both the mechanisms and the limitations of single receptor approaches.

GLP-1Retatrutidemetabolicincretinmechanism
Read Guide
Intermediate10 min read

How NAD+ Works: Sirtuins, DNA Repair, and the Science of Cellular Aging

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every living cell, serving as the essential substrate for sirtuins, PARPs, and CD38, with its depletion increasingly recognized as a mechanistic driver of aging. NAD+ is described in popular science as a longevity molecule, accurate but incomplete. Understanding why researchers study NAD+ restoration requires understanding the three major enzymatic systems that consume it, how aging disrupts that consumption balance, and what happens at the molecular level when NAD+ is depleted.

NAD+sirtuinsDNA repairagingmechanism
Read Guide
🔬
Intermediate9 min read

How Research Peptides Are Made: A Plain English Guide to Synthesis, Purity, and Quality

Peptide synthesis is a process by which amino acids are assembled sequentially using solid-phase or liquid-phase chemistry, with synthesis quality determining the purity and research utility of the final compound. Research peptide quality is determined before the vial reaches the researcher, at every step from amino acid selection through final lyophilization. Understanding the synthesis process helps researchers evaluate quality claims, interpret COA data, and identify inadequate sourcing.

peptide synthesisHPLCpuritymanufacturingquality
Read Guide
🩸
Intermediate9 min read

What Is Angiogenesis? The Blood Vessel Biology Behind Repair Peptide Research

Angiogenesis is a biological process by which new blood vessels form from pre-existing vasculature, essential for wound healing and tissue repair, and the primary mechanism through which BPC-157 promotes tissue recovery in preclinical research. Blood vessels are not passive pipes. They are dynamic, actively maintained structures that determine whether tissue lives or dies. Understanding angiogenesis explains why so much tissue repair research focuses on vascular biology, and why compounds like BPC-157 occupy such a central position in recovery peptide research.

angiogenesisBPC-157GHK-Cutissue repairblood vessels
Read Guide
🦴
Intermediate10 min read

Peptides and Tendon Repair: The BPC-157 and TB-500 Research, Explained

This guide is a research overview of peptides studied for tendon repair, particularly BPC-157 and TB-500, covering the biological challenges of tendon healing and preclinical evidence for peptide-based interventions. Tendon injuries are among the most frustrating in sports medicine and orthopedic research because standard repair timelines can stretch to months or years despite optimal conservative management. The biological reason for this is structural, and it is what makes tendon the primary tissue of interest for angiogenesis and cell migration-focused repair research.

BPC-157TB-500tendon repairligamenttissue repair
Read Guide
🧠
Intermediate10 min read

Peptides and Cognitive Decline: What the Neuroprotection Research Shows

This guide is a research overview of peptides studied for cognitive decline, covering compounds including Semax, Selank, Dihexa, and Cerebrolysin that target BDNF, HGF/c-Met, and neurotrophic signaling pathways. Cognitive aging involves multiple simultaneous biological processes, including synaptic loss, BDNF decline, neuroinflammation, and mitochondrial dysfunction in neurons, each potentially addressable by different research compounds. The landscape of neuroprotective peptide research reflects this biological complexity.

cognitive declineneuroprotectionCerebrolysinSemaxDihexaSelank
Read Guide
🔬
Intermediate10 min read

Peptides and Metabolic Syndrome: What the Research Is Finding

Metabolic syndrome is not a single disease. It is a cluster of interrelated metabolic dysfunctions that co-occur and mutually reinforce each other. This multi-driver nature means that single-mechanism interventions may produce limited effects, and that research compounds targeting different metabolic pathways have complementary rather than competing research rationale.

metabolic syndromeRetatrutideMOTS-cNAD+insulin resistance
Read Guide
🌿
Intermediate10 min read

Peptides and Inflammatory Bowel Research: What BPC-157 and KPV Studies Show

This guide is a research overview of peptides studied for inflammatory bowel disease, particularly BPC-157 and KPV, which target gut barrier integrity and intestinal inflammation through complementary mechanisms. Inflammatory bowel disease represents one of the clearest research opportunities for peptide compounds, a condition driven by measurable biological mechanisms that specific peptides directly target. Understanding why BPC-157 and KPV appear repeatedly in IBD research requires understanding the gut inflammation biology that makes them mechanistically relevant.

IBDBPC-157KPVgut healthinflammatory bowel
Read Guide
🩹
Intermediate10 min read

Peptides and Wound Healing: The GHK-Cu and BPC-157 Evidence, Explained

Peptides play a central role in wound healing biology. Several compounds have been studied specifically for their ability to accelerate tissue repair, reduce inflammation, and restore structural integrity in preclinical models. BPC-157, TB-500, and GHK-Cu represent the three most researched peptides in this space, each operating through distinct mechanisms.

wound healingGHK-CuBPC-157tissue repair
Read Guide
❤️
Intermediate9 min read

Peptides and Cardiac Research: What SS-31 and TB-500 Studies Show

This guide is a research overview of peptides studied for cardiac biology, particularly SS-31 and TB-500, which target mitochondrial function and tissue repair in the heart's uniquely demanding metabolic environment. The heart presents unique biological challenges for repair research: it is the most metabolically demanding tissue in the body, has minimal regenerative capacity in adult mammals, and contains some of the densest mitochondrial concentrations of any organ. These characteristics explain why SS-31 and TB-500 have both accumulated substantial cardiac research histories.

SS-31TB-500cardiacmitochondriarepair
Read Guide
📋
Intermediate9 min read

How to Design a Research Protocol: A Practical Framework for Peptide Researchers

This guide is a structured framework for designing peptide research protocols, covering the methodological decisions that determine whether a study generates interpretable data, from compound selection to measurement endpoints. Research protocol design separates data that can answer a question from data that cannot. This guide covers the core methodological decisions that determine whether a peptide research protocol will generate interpretable results, regardless of which compound is being studied.

research designprotocolmethodologydocumentation
Read Guide
📊
Intermediate8 min read

Understanding Dose-Response in Peptide Research: What the Literature Shows

A dose-response relationship is a fundamental pharmacological concept in which the same compound produces different effects at different doses, defining the optimal research dose range for a given peptide and model system. The dose-response relationship is the most fundamental concept in pharmacology: the same compound can produce different effects at different doses, and optimal research dose ranges are defined by published literature, not by intuition. Understanding dose-response in the context of research peptides helps researchers interpret published data and design more informative protocols.

dose responsepharmacologyresearch designprotocol
Read Guide
💉
Intermediate8 min read

Subcutaneous vs Intramuscular vs Intranasal: Understanding Peptide Administration Routes

Peptide administration route is a critical research design variable that determines blood concentration curves, tissue distribution, and onset profiles, with subcutaneous, intraperitoneal, and oral routes each producing distinct pharmacokinetic results. Administration route is one of the most consequential decisions in peptide research design. The same compound administered by different routes may produce different blood concentration curves, different tissue distribution patterns, and different onset and duration profiles. Understanding why requires understanding what each route actually does to a peptide.

administration routesbioavailabilitysubcutaneousintranasal
Read Guide
⏱️
Intermediate8 min read

Half-Life and Dosing Frequency: What Peptide Pharmacokinetics Actually Mean

Peptide half-life is a pharmacokinetic measurement of how quickly a compound leaves the bloodstream, distinct from biological effect duration, and a key variable in designing dosing frequency for research protocols. Half-life is the most commonly misunderstood concept in peptide pharmacokinetics. Knowing a compound's half-life tells you how quickly it leaves the bloodstream, but not how long its biological effects persist. Understanding this distinction helps researchers design dosing frequency rationally rather than by intuition.

half-lifepharmacokineticsdosingresearch design
Read Guide
📖
Intermediate9 min read

How to Interpret a Phase 2 Clinical Trial: A Researcher's Guide

A Phase 2 clinical trial is a controlled human study that generates primary evidence for compound efficacy and dose range, and understanding how to read its data is essential for researchers evaluating peptide and metabolic compound research. Phase 2 clinical trial data is the gold standard for human efficacy evidence in metabolic and peptide research, but only if you know how to read it correctly. Understanding what Phase 2 trials can and cannot tell you determines whether published data actually informs your research or simply creates false confidence.

clinical trialsphase 2research skillsevidence
Read Guide
🧩
Intermediate10 min read

Cerebrolysin: What the Clinical Trial Data Actually Shows

Cerebrolysin is a standardized neuropeptide mixture that is unique among research compounds in having multiple published randomized controlled trials, regulatory approval in several countries, and decades of clinical use data. Cerebrolysin occupies a unique position in cognitive research: it is the only peptide mixture in the research catalog with multiple published randomized controlled trials, regulatory approval in some countries, and decades of clinical use data. This evidence base makes it fundamentally different from compounds with only preclinical data.

Cerebrolysinclinical trialsneuroprotectionAlzheimerscognitivebrain healthnootropic
Read Guide
🛡️
Intermediate9 min read

KPV: The Alpha-MSH Fragment and Melanocortin Receptor Research

KPV is a C-terminal tripeptide fragment (Lys-Pro-Val) of alpha-melanocyte-stimulating hormone, studied as a potent anti-inflammatory agent that acts through the melanocortin receptor system to suppress gut and systemic inflammation. KPV is derived from alpha-MSH, one of the endogenous hormones that regulate inflammation, pigmentation, and energy balance through the melanocortin receptor system. Understanding why this three-amino-acid fragment retains anti-inflammatory activity requires understanding the melanocortin system and how receptor binding relates to inflammatory signaling.

KPValpha-MSHmelanocortinIBDinflammation
Read Guide
💡
Intermediate9 min read

Dihexa and HGF/c-Met: The Synaptogenesis Research Explained

Dihexa is a synthetic peptide analogue developed at Washington State University as an orally bioavailable agonist of the HGF/c-Met signaling pathway, studied for its potent pro-cognitive effects in preclinical models of synaptic formation. Dihexa was developed at Washington State University through a systematic search for compounds that activate hepatocyte growth factor signaling in the brain, a pathway that had been identified in published research as a direct driver of synaptogenesis. The subsequent pharmacological data produced one of the most striking potency findings in recent cognitive research.

DihexaHGFc-Metsynaptogenesiscognitiveneuroprotectionbrain healthnootropic
Read Guide
Intermediate9 min read

GHK-Cu and Gene Expression: The Pickart Research and What It Means

GHK-Cu is a naturally occurring copper-binding tripeptide (Glycyl-L-Histidyl-L-Lysine) found in human plasma that has been shown to modulate the expression of over 4,000 human genes toward a regenerative state. GHK-Cu is among the most studied small peptides in biology, with a research history spanning over 50 years. The discovery that this naturally occurring tripeptide influences the expression of hundreds of genes, far exceeding what would be expected from a three amino acid sequence, raised fundamental questions about how endogenous peptides regulate biology at scale.

GHK-Cugene expressioncollagenPickartwound healing
Read Guide
🔬
Advanced11 min read

BPC-157 Protocol Science: What Published Research Actually Used

This BPC-157 research protocol guide is a structured compilation of doses, routes, and timing from published preclinical studies, providing researchers with published precedent for designing evidence-anchored protocols. One of the most common questions in BPC-157 research is deceptively simple: what did the published studies actually use? Not what a forum recommends, not what a vendor suggests, but the exact doses, routes, and timing protocols that produced the results now cited in systematic reviews and meta-analyses. This article compiles that information directly from the literature so researchers designing protocols can anchor their work in published precedent. For the full compound profile, see the BPC-157 deep dive.

BPC-157 protocolBPC-157 dosage protocolBPC-157 research protocolBPC-157 administrationBPC-157 dosesubcutaneous BPC-157
Read Guide
Advanced11 min read

TB-500 Protocol Science: Dose Ranges, Loading Phases, and Timing From the Literature

This TB-500 research protocol guide is a structured review of administration protocols from published studies, covering the doses, routes, and schedules used in cardiac, musculoskeletal, and neurological research models. TB-500, the synthetic fragment of Thymosin Beta 4 (Tβ4, a 43-amino-acid ubiquitous protein originally isolated from thymic tissue that plays a central role in actin dynamics and tissue repair signaling), has a published research history that spans cardiac repair, skeletal muscle recovery, corneal healing, and neurological injury models. Understanding what published studies actually administered, and why, is essential for researchers designing protocols with scientific rigor.

TB-500 protocolTB-500 dosageTB-500 research protocolthymosin beta 4 protocolTB-500 doseTB-500 administration
Read Guide
🧬
Advanced11 min read

Retatrutide Protocol Science: Phase 2 Dose Escalation, Timing, and Research Design

This Retatrutide research protocol guide is a structured overview of the Phase 2 clinical dose-escalation protocol, providing researchers with the most directly applicable human data for this triple incretin agonist. Retatrutide is the first published triple receptor agonist for the GLP-1, GIP, and glucagon receptors to reach Phase 2 clinical trials with published efficacy data. Unlike many research peptides where protocol guidance must be inferred from preclinical studies, Retatrutide has a published human dose-escalation protocol (the 2023 NEJM Phase 2 trial) that provides direct, high-quality data on how this compound was administered, what doses were studied, and what the onset timeline looks like.

retatrutide dosageretatrutide protocolretatrutide doseretatrutide administrationretatrutide research protocolGLP-1 GIP glucagon protocol
Read Guide
Advanced11 min read

IV NAD+ Protocol Science: What Published Research Uses and Why the Route Matters

This NAD+ IV therapy research protocol guide is a structured overview of intravenous NAD+ administration from published clinical studies, covering concentration, delivery rate, and pharmacokinetic considerations. Intravenous NAD+ administration bypasses the conversion bottlenecks that limit oral NAD+ precursors like NMN and NR. For researchers interested in rapidly restoring intracellular NAD+ to supraphysiological levels, or studying the pharmacology of direct NAD+ repletion, iV delivery represents the reference protocol against which all oral approaches are ultimately compared. This article examines what published protocols have used and why.

NAD+ IV therapyIV NAD protocolNAD infusion protocolintravenous NADNAD+ research protocolNAD+ dosage research
Read Guide
🧩
Advanced11 min read

Cerebrolysin Protocol Science: Clinical Protocols from Published Literature

This Cerebrolysin research protocol guide is a structured overview of doses, routes, and course lengths from published clinical trials, providing researchers with the most rigorously validated protocol data in the neuropeptide category. Cerebrolysin has something most research compounds lack: a published clinical protocol record derived from decades of structured clinical trials in Europe and Russia. Unlike peptides where researchers must extrapolate from preclinical data, Cerebrolysin's protocol landscape includes published Phase 2 and Phase 3 trials, systematic reviews, and regulatory submission dossiers that specify exactly what doses, routes, and course lengths were used in patients with measurable neurological outcomes.

cerebrolysin protocolcerebrolysin dosagecerebrolysin research protocolcerebrolysin administrationcerebrolysin dosecerebrolysin clinical protocol
Read Guide
Advanced11 min read

GHK-Cu Protocol Science: Topical, Systemic, and Published Dose Ranges

This GHK-Cu research protocol guide is a structured overview of topical and systemic administration approaches from published skin biology and wound healing studies. GHK-Cu (glycine-histidine-lysine copper complex) has been studied in two fundamentally different research contexts: topical application for skin biology, and systemic injection for wound healing and tissue repair. Each context has its own concentration standards, application frequency norms, and published precedent. Understanding which context applies to a given research question is the first step in designing an appropriate protocol.

GHK-Cu protocolcopper peptide protocolGHK-Cu dosageGHK-Cu administrationGHK-Cu concentrationcopper peptide research protocol
Read Guide
💨
Advanced11 min read

Nitric Oxide and Peptide Biology: The eNOS Pathway BPC-157 Researchers Study

Nitric oxide (NO) is a gaseous signaling molecule that regulates angiogenesis, modulates inflammation, controls blood pressure, and participates in tissue repair, forming a central mechanistic pathway for BPC-157 and related research compounds. Nitric oxide (NO) is not merely a relaxing molecule for blood vessels. It is a gaseous signaling molecule that regulates angiogenesis, modulates inflammation, controls blood pressure, participates in neurological function, and is central to the tissue repair cascade that BPC-157 researchers have been studying for decades. Understanding the NO pathway, and specifically how BPC-157 engages it differently from crude substrate supplementation, is essential for researchers building mechanistic models of BPC-157's effects.

nitric oxide peptidepeptide nitric oxide pathwayBPC-157 nitric oxideeNOS peptideangiogenesis nitric oxideNO signaling research
Read Guide
🧬
Advanced11 min read

Telomeres, NAD+, and Longevity Biology: What Peptide Research Is Finding

Telomere research is a field studying the molecular countdown mechanisms that regulate cellular lifespan, with NAD+ signaling, mitochondrial health, and sirtuins as the key research targets connecting peptide biology to telomere maintenance. Telomeres are the molecular countdown clocks of the cell. Every time a cell divides, they get a little shorter, until they reach a critical length that triggers cellular senescence or apoptosis. The connection between telomere length and aging is one of the most firmly established in molecular biology. What's less commonly understood is how NAD+ signaling, mitochondrial health, and specific peptide research compounds connect to telomere maintenance biology.

telomere peptidetelomere researchNAD+ telomerepeptide telomere lengtheningtelomere aging researchSIRT6 telomere
Read Guide
♻️
Advanced11 min read

Autophagy Biology: How NAD+, MOTS-c, and BPC-157 Engage Cellular Cleanup

Autophagy is a cellular process by which damaged proteins and dysfunctional organelles are delivered to lysosomes for degradation and recycling, recognized as a hallmark quality-control mechanism that declines with age and is a research target for NAD+, MOTS-c, and BPC-157. Autophagy (literally "self-eating" in Greek) is the cellular process by which damaged proteins, dysfunctional organelles, and pathogen-containing compartments are delivered to lysosomes for degradation and recycling. It is one of the most fundamental quality-control mechanisms in biology, and its decline with age is recognized as a hallmark of cellular aging. Multiple research compounds including NAD+, MOTS-c, and BPC-157 have published connections to autophagy biology worth understanding in mechanistic depth.

autophagy peptidepeptide autophagy activationNAD+ autophagyMOTS-c autophagyautophagy researchULK1 autophagy pathway
Read Guide
📈
Advanced11 min read

Growth Hormone Biology: The Axis Behind Semax, NAD+, and Metabolic Peptide Research

A growth hormone secretagogue is a compound that stimulates endogenous growth hormone release from the pituitary, distinct from direct GH administration, and studied for effects on body composition, tissue repair, and metabolic function. Growth hormone is not just about growth. The GH/IGF-1 axis regulates body composition, metabolism, tissue repair, immune function, and cognitive biology, making it relevant to a broad range of research programs. Understanding how this axis operates, how it declines with age, and how research compounds might interact with it (without direct GH administration) is essential background for anyone studying Semax, metabolic peptides, or longevity biology.

growth hormone peptideGH secretagogue researchGHRH peptideIGF-1 pathway researchgrowth hormone axisSemax GH research
Read Guide
🔀
Advanced11 min read

mTOR Biology: How MOTS-c, SS-31, and NAD+ Interact With the Longevity Switch

mTOR (mechanistic target of rapamycin) is a protein kinase that is a central signaling node in longevity biology, integrating nutrient and growth factor signals to regulate cell growth, metabolism, and maintenance programs, with inhibition extending lifespan in all tested model organisms. mTOR is perhaps the most important signaling node in longevity biology. It integrates nutrient availability, energy status, growth factor signals, and stress inputs to determine whether the cell should grow, divide, or activate maintenance and repair programs. Its inhibition extends lifespan in every model organism where it has been tested. Understanding how research compounds interact with mTOR signaling, directly and indirectly, is essential for anyone working in aging or metabolic research.

mTOR peptidemTOR activation peptide researchMOTS-c mTORAMPK mTOR pathwaymTOR longevity researchmTORC1 research
Read Guide
🌐
Advanced11 min read

The Gut-Brain Axis: How BPC-157, KPV, and GLP-1 Research Connects Two Systems

The gut-brain axis is a bidirectional communication system between the intestine and the brain, involving vagal nerves, circulating peptides, and microbiome metabolites, and the mechanistic basis for research into BPC-157, KPV, and GLP-1 analogs. The gut-brain axis is one of the most intensively studied bidirectional communication systems in modern biology. The intestine contains more neurons than the spinal cord, produces 90% of the body's serotonin, and communicates with the brain through vagal afferents, circulating peptides, and microbiome-derived metabolites. Research compounds studied for gut health, BPC-157, KPV, and GLP-1 analogs, interact with this system in ways that extend their research relevance well beyond gastrointestinal endpoints.

gut brain axis peptidegut brain peptide researchBPC-157 gut brainKPV gut brainGLP-1 gut brain axisenteric nervous system research
Read Guide
📋
Advanced11 min read

BPC-157 Human Evidence: A Systematic Review of What the Research Actually Shows

BPC-157 is a synthetic 15-amino acid peptide derived from a protective protein found in human gastric juice, with one of the largest preclinical research databases of any research peptide but no published randomized controlled trials in humans. BPC-157 has one of the largest preclinical research databases of any research peptide. Over 100 published studies spanning more than three decades have documented effects across a wide range of tissue types and injury models. Yet there are no published randomized controlled trials in human subjects. Understanding what this evidence architecture means, and what it does not mean, is essential for researchers approaching BPC-157 honestly.

BPC-157 human studiesBPC-157 clinical trialBPC-157 evidencetissue repairrecoveryhealingangiogenesis
Read Guide
🧠
Advanced11 min read

Cerebrolysin and Alzheimer's Disease: A Review of the Published Clinical Trial Data

Cerebrolysin is a standardized mixture of low-molecular-weight neuropeptides and free amino acids derived from purified porcine brain proteins, registered as an Alzheimer's disease treatment in multiple countries based on published clinical trial data. Cerebrolysin is registered as a drug for treatment of Alzheimer's disease in multiple countries including Austria, China, Korea, and several Eastern European and Asian nations. This regulatory status is based on published clinical trial data that has been reviewed by national regulatory authorities, yet Cerebrolysin has not received FDA or EMA approval. Understanding the evidence base that supports regulatory approval in some jurisdictions but not others requires examining the data carefully.

cerebrolysin Alzheimerscerebrolysin dementia researchcerebrolysin clinical trial reviewcerebrolysin MCI evidencecerebrolysin ADAS-cogcerebrolysin neuroprotection evidence
Read Guide
📊
Advanced11 min read

Retatrutide Phase 2 NEJM Data: A Line-by-Line Research Analysis

Retatrutide (LY3437943) is a synthetic triple incretin receptor agonist whose June 2023 NEJM Phase 2 trial demonstrated up to 24% body weight reduction at 48 weeks, making it the most significant metabolic pharmacology publication of that year. The June 2023 NEJM publication of the Phase 2 Retatrutide trial (PMID 37352392) was arguably the most significant single metabolic pharmacology paper of that year. It demonstrated that triple receptor agonism (GLP-1, GIP, and glucagon receptors simultaneously) could produce body weight reductions of up to 24% at 48 weeks, a magnitude that challenged assumptions about the ceiling of pharmacological weight management. This is a line-by-line analysis of what the paper actually shows.

RetatrutideGLP-1GIPglucagonweight lossmetabolic healthtriple agonistobesity research
Read Guide
Advanced11 min read

NAD+ Longevity Research: A Review of Published Human Trial Data

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every living cell whose longevity research has generated the first generation of human NMN and NR clinical trials, published between 2016 and 2023, providing the best available human evidence. The first generation of human NMN and NR clinical trials was published between 2016 and 2023, transforming NAD+ longevity research from a purely animal-model field to one with preliminary human data. These studies are small, short, and exploratory, but they are the best available human evidence, and understanding what they showed (and what they didn't show) is essential for researchers designing NAD+ protocols.

NAD+ longevity researchNMN clinical trial resultsNAD supplementation studyNMN human trialNAD+ aging research reviewNR vs NMN human data
Read Guide
🧠
Advanced11 min read

Semax Clinical Evidence: A Review of the Russian Research Program

Semax is unusual among research peptides: it is a registered pharmaceutical drug in Russia and Ukraine, with a clinical development program that produced the regulatory data required for national drug approval. This clinical history distinguishes it from compounds with only preclinical data. Understanding the clinical evidence base, and why registration in Russia doesn't mean FDA approval, requires examining the research program in detail.

semax researchsemax clinical trialsemax neuroprotection evidencecognitiveneuroprotectionbrain healthnootropicBDNF
Read Guide
🔋
Advanced11 min read

Elamipretide (SS-31) Clinical Evidence: Phase 2 Data and What It Shows

Elamipretide (SS-31) is a synthetic tetrapeptide that selectively targets the inner mitochondrial membrane and is one of the very few research peptides to have completed multiple Phase 2 clinical trials with published results. Elamipretide (the clinical name for SS-31) is one of the very few research peptides to have completed multiple Phase 2 clinical trials with published results. Stealth BioTherapeutics, the clinical-stage company that developed elamipretide, conducted trials in Barth syndrome, heart failure, and primary mitochondrial disease. These trials provide the human clinical evidence base for SS-31's mitochondrial targeting mechanism, and the story is instructive in both its successes and setbacks.

SS-31 peptide researchelamipretide clinical trialSS-31 mitochondria evidenceelamipretide phase 2SS-31 heart failure researchBarth syndrome research
Read Guide
⚖️
Advanced11 min read

Retatrutide vs Tirzepatide vs Semaglutide: A Three-Way Mechanism and Trial Comparison

Semaglutide, tirzepatide, and retatrutide represent three generations of incretin-based metabolic compounds. Each adds receptor targets to the previous generation: semaglutide targets GLP-1, tirzepatide adds GIP, and retatrutide adds glucagon on top of both. Phase 2 and 3 trial data shows a clear progression in weight loss efficacy across this series.

retatrutide vs tirzepatideretatrutide vs semaglutide vs tirzepatideretatrutide comparisonGLP-1 vs dual vs triple agonistsemaglutide vs tirzepatide vs retatrutidetriple receptor agonist comparison
Read Guide
🔬
Advanced11 min read

NMN vs NR vs IV NAD+: A Three-Way Bioavailability and Efficacy Comparison

This guide is a direct comparison of NMN, NR, and IV NAD+ as approaches to NAD+ restoration research, covering their different metabolic pathways, tissue distribution patterns, onset kinetics, and practical research considerations. The question of whether to use NMN, NR, or IV NAD+ for NAD+ restoration research is not merely a question of bioavailability. It involves different metabolic pathways, different tissue distribution patterns, different onset kinetics, and different practical research considerations. This comparison provides the mechanistic and empirical framework for making a principled choice between the three approaches.

NMN vs NRNMN vs NR vs NAD+which is better NMN or NRNMN NR comparison researchIV NAD vs oralNAD+ precursor comparison
Read Guide
🔀
Advanced11 min read

BPC-157 vs Ipamorelin/CJC-1295: Two Research Compounds, Two Entirely Different Targets

This guide is a direct comparison of BPC-157 and the Ipamorelin/CJC-1295 combination: two mechanistically unrelated research compounds targeting different biological systems with different evidence bases and research rationales. BPC-157 and the Ipamorelin/CJC-1295 combination are frequently discussed together in research communities, often as if they were alternatives or competing approaches to the same biological goal. They are not. They target entirely different biological systems, have different evidence bases, and address different research questions. Understanding this distinction is necessary for designing mechanistically coherent research protocols.

BPC-157 vs ipamorelinBPC-157 ipamorelin stackBPC-157 CJC comparisonBPC-157 vs growth hormone peptideBPC-157 research comparisonipamorelin CJC mechanism
Read Guide
Advanced11 min read

GHK-Cu vs Retinol: A Mechanism-Based Comparison for Researchers

This guide is a direct comparison of GHK-Cu, Retinol, and peptide skincare compounds: three evidence-supported approaches to skin biology that operate through distinct mechanisms with different timelines and tolerability profiles. Retinol and GHK-Cu are the two most evidence-supported topical skin biology agents in the published literature. Yet they work through completely different mechanisms, produce different timelines of effects, and carry different tolerability profiles. Understanding the mechanistic differences is essential for researchers designing skin biology studies and for interpreting the published comparison data.

GHK-Cu vs retinolcopper peptide vs retinolGHK-Cu retinol comparisoncopper peptide vs vitamin Aanti aging peptide skincare research
Read Guide
Advanced11 min read

NAD+ vs CoQ10 vs SS-31: Three Distinct Approaches to Mitochondrial Research

This guide is a direct comparison of NAD+, CoQ10, and SS-31 as mitochondrial health research compounds, covering how they address different aspects of mitochondrial biology with distinct mechanisms and research rationales. Three compounds dominate discussions of mitochondrial health research: NAD+ (and its precursors), CoQ10 (ubiquinone/ubiquinol), and SS-31 (elamipretide). They are frequently grouped together as "mitochondrial supplements," but they address entirely different aspects of mitochondrial biology. Understanding what each does mechanistically, and what it cannot do, is essential for designing coherent mitochondrial research protocols.

NAD+ vs CoQ10CoQ10 vs NMNmitochondria peptide comparisonNAD CoQ10 SS-31mitochondrial research compounds
Read Guide
🔬
Advanced11 min read

Peptides vs TRT: Two Entirely Different Research Paradigms

This guide is a direct comparison of research peptides and testosterone replacement therapy (TRT): two fundamentally different approaches to aging, performance, and tissue health research with distinct mechanisms and risk profiles. The comparison between testosterone replacement therapy (TRT) and research peptides reflects two fundamentally different approaches to the biology of aging, performance, and tissue health. They operate through different receptor systems, produce different physiological changes, and have entirely different risk profiles. Understanding the mechanistic distinctions is the first step toward understanding why they are not alternatives to each other.

peptide vs TRTpeptides instead of testosteroneresearch peptides testosterone alternativeTRT vs peptide researchtestosterone vs peptide comparisonHPG axis vs peptide research
Read Guide
🕰️
Advanced12 min read

The Anti-Aging Research Stack: NAD+, MOTS-c, SS-31, and GHK-Cu From First Principles

Aging is not a single process. It is a convergence of at least nine distinct biological failures: mitochondrial dysfunction, NAD+ depletion, genomic instability, telomere attrition, epigenetic drift, loss of proteostasis, cellular senescence, stem cell exhaustion, and altered intercellular communication. No single compound addresses all nine. But when researchers map specific compounds to specific hallmarks, a layered research architecture begins to emerge. This article builds that architecture from first principles. Each layer has a distinct mechanism, a distinct evidence base, and a distinct research rationale. Understanding why each compound belongs, rather than simply accepting that they do, is the difference between a protocol and a prescription.

anti-aging peptide protocolbest anti-aging peptideslongevity peptide researchanti aging peptide stackpeptide longevity protocol researchNAD MOTS-c SS-31 GHK-Cu stack
Read Guide
🏋️
Advanced11 min read

Athletic Recovery Research: BPC-157, TB-500, GHK-Cu, and NAD+ From First Principles

This athletic recovery research protocol is a structured framework for studying the four simultaneous biological repair processes in exercise-stressed tissue: inflammation resolution, connective tissue remodeling, matrix repair, and mitochondrial resynthesis. Recovery from athletic stress is not a single process. It is four separate biological events happening simultaneously in different tissue compartments, on different timescales, through different molecular mechanisms. Inflammation resolution in damaged muscle. Connective tissue remodeling at tendon attachment points. Extracellular matrix repair in fascia and ligament. Mitochondrial resynthesis in muscle fibers recovering from substrate depletion. Most single-compound recovery research addresses only one of these processes. A multi-layer approach, anchored in the distinct mechanisms of BPC-157, TB-500, GHK-Cu, and NAD+, gives researchers the tools to study all four simultaneously or in isolation.

peptide for recoverybest peptides for athletespeptide recovery protocolBPC-157 TB-500 stackathletic recovery peptide researchsports recovery peptide protocol
Read Guide
🧠
Advanced11 min read

The Neuroprotection Research Stack: Cerebrolysin, Semax, Selank, and NAD+

This neuroprotection research protocol is a structured framework for studying four mechanistic layers of CNS protection: trophic factor support, BDNF upregulation, stress axis modulation, and mitochondrial protection. Neuroprotection research studies one of the most complex challenges in biology: how to maintain and restore function in a tissue that cannot replace its cells. Unlike the liver, which can regenerate lost hepatocytes, or skin, which continuously renews, neurons that die are generally gone forever. The brain's limited regenerative capacity makes protection, preventing damage before it occurs or limiting it after it begins, the primary research strategy. Four distinct mechanistic layers define the published neuroprotection research landscape: trophic factor support (providing the molecular signals neurons need to survive under stress), BDNF upregulation (stimulating the brain's most important plasticity-promoting growth factor), stress axis modulation (reducing the glucocorticoid and oxidative damage that stress inflicts on neurons), and mitochondrial protection (preserving the energy supply that neurons depend on absolutely).

neuroprotection peptidepeptide brain protectionnootropic peptide protocol advancedCerebrolysin Semax Selank stackneuroprotection research stackadvanced nootropic peptide research
Read Guide
🔥
Advanced11 min read

Metabolic Research Stack: Retatrutide, MOTS-c, and NAD+ From First Principles

This metabolic optimization research protocol is a structured framework for studying cellular energy homeostasis at three distinct scales: whole-body hormonal signaling, intracellular energy sensing, and gene-level metabolic programming. Metabolic disease is ultimately a failure of cellular energy homeostasis, the complex system by which cells sense nutrient availability, signal to the brain, regulate appetite, partition fuel between storage and oxidation, and adapt mitochondrial capacity to metabolic demand. No single intervention can correct this system comprehensively because the system operates at three distinct scales: whole-body hormonal signaling (appetite, insulin secretion, glucagon), intracellular energy sensing (AMPK, mTOR, sirtuins), and gene-level metabolic programming (transcription factors controlling the expression of enzymes, transporters, and mitochondrial components). Retatrutide, MOTS-c, and NAD+ address these three scales respectively, providing a mechanistically complete framework for metabolic research.

peptide for metabolismmetabolic peptide protocolresearch peptides weight loss protocolretatrutide MOTS-c NAD stackmetabolic optimization researchadvanced metabolic peptide research
Read Guide
🩹
Advanced11 min read

Advanced Wound Healing Research: KPV, BPC-157, GHK-Cu, and TB-500 by Phase

Wound healing is a masterpiece of biological coordination: four overlapping phases, dozens of cell types, hundreds of molecular signals, executed in a precise temporal sequence that, when functioning correctly, rebuilds damaged tissue in days to weeks. When it fails - as it does in diabetic ulcers, pressure injuries, venous ulcers, and radiation wounds - the consequences are severe. Chronic wounds affect over 6 million people in the United States alone, with enormous costs in morbidity and healthcare resources. The published research on peptide compounds in wound biology maps neatly onto this phase-based architecture. KPV addresses Phase 1. BPC-157 addresses Phase 2. GHK-Cu addresses Phase 3. TB-500 enhances Phase 4. Understanding the biology behind each assignment is the foundation of intelligent research protocol design.

peptide wound healing protocoladvanced wound healing researchchronic wound peptide researchBPC-157 KPV GHK-Cu wound stackwound healing peptide protocoltissue repair research protocol
Read Guide
🌿
Advanced12 min read

IBD and Gut Research: BPC-157 and KPV Mechanisms, Evidence, and Protocol Design

This IBD gut research protocol is a structured framework for studying inflammatory bowel disease using BPC-157 and KPV, two peptides that address different molecular aspects of gut inflammation through complementary mechanisms. Inflammatory bowel disease occupies a unique position in research medicine: it is mechanistically complex enough that no single molecular intervention has proven curative, yet specific enough in its biology that targeted peptide research has produced some of the most compelling preclinical data in gastroenterology. BPC-157 and KPV have become the most studied peptide compounds in IBD models for complementary reasons, addressing different molecular aspects of gut inflammation through non-overlapping mechanisms that together cover the primary pathophysiological features of colitis and Crohn's disease. This article builds the mechanistic case from first principles: what IBD actually is at the molecular level, how each compound addresses a specific failure mode, and how researchers have designed experiments to test these mechanisms in published models.

peptide IBD researchgut healing peptide protocolBPC-157 Crohns researchKPV gut researchIBD peptide research protocolBPC-157 colitis research
Read Guide
💪
Intermediate9 min read read

Best Peptides for Muscle & Tissue Recovery

Recovery from injury, training, and physical stress involves several overlapping biological processes: tissue repair, inflammation resolution, and restoration of function. Peptide research has identified compounds that target each of these stages. This guide covers the evidence for the most-studied recovery peptides and how they compare.

RecoveryBPC-157TB-500Tissue Repair
Read Guide
🧠
Intermediate10 min read read

Best Peptides for Cognitive Enhancement Research

Cognitive performance in research contexts is typically measured by learning and memory tasks, anxiety reduction, and neuroprotective outcomes. Several peptides have been studied specifically for these endpoints, with varying levels of preclinical and clinical evidence. This guide compares the most relevant compounds and what the evidence says about each.

CognitiveSemaxSelankDihexaNootropics
Read Guide
Intermediate10 min read read

Best Peptides for Longevity & Anti-Aging Research

This guide is a structured comparison of the best-studied longevity research compounds: NAD+ precursors, MOTS-c, SS-31, and GHK-Cu, evaluated based on published mechanistic and preclinical aging research. Longevity peptide research has emerged as one of the most active areas of preclinical biology, with several compounds demonstrating measurable effects on aging hallmarks in animal models. This article compares four of the leading longevity research compounds: NAD+ precursors, MOTS-c, SS-31, and GHK-Cu, based on published mechanistic and animal model data. See also: anti-aging research protocol for a deeper dive.

LongevityAnti-AgingNAD+MOTS-cSS-31
Read Guide
Intermediate8 min read read

Best Peptides for Skin & Dermatological Research

This guide is a structured comparison of the best-studied peptides for skin biology: GHK-Cu, KPV, and BPC-157, evaluated based on published wound healing, collagen synthesis, and anti-inflammatory research. Dermatological peptide research is one of the most active areas of skin biology, with compounds like GHK-Cu, KPV, and BPC-157 demonstrating measurable effects on wound healing, collagen synthesis, and inflammatory skin conditions in published preclinical studies. This article reviews their mechanisms and compares their research profiles. See also: GHK-Cu protocol guide and peptides for skin.

SkinGHK-CuKPVCollagenWound Healing
Read Guide
⚖️
Intermediate10 min read read

Best Peptides for Metabolic & Weight Loss Research

Metabolic peptide research has accelerated significantly since the clinical success of GLP-1 receptor agonists. Several research compounds target weight loss and metabolic regulation through mechanisms ranging from appetite suppression to thermogenesis to fat oxidation. This guide covers the peptides most relevant to weight loss research and what the trial data shows.

MetabolicRetatrutideGLP-1Weight LossMOTS-c
Read Guide
🔬
Education8 min read read

Blackwell BioLabs - Research Standards & Quality Commitment

Blackwell BioLabs is a USA-based research peptide supplier committed to providing the highest-purity research compounds with transparent, independent third-party verification. Every batch we supply comes with a Certificate of Analysis confirming ≥99% purity by HPLC, mass spectrometry identity confirmation, and endotoxin testing. Our research standards align with what we describe in peptide purity standards.

QualityCOATestingStandardsAbout
Read Guide
📊
Advanced10 min read

Retatrutide Phase 3 (TRIUMPH Program): What the Trials Are Designed to Answer

The TRIUMPH Phase 3 program for retatrutide (LY3437943) is a multi-trial series designed to confirm Phase 2 efficacy in larger populations, characterize long-term safety, and generate the cardiovascular outcomes data required for regulatory submission.

retatrutide phase 3TRIUMPH trial retatrutideretatrutide clinical trial 2024retatrutide Eli Lilly phase 3retatrutide obesity trialLY3437943 phase 3
Read Guide
🔬
Advanced11 min read

Epithalon (AEDG) Clinical Evidence: Khavinson's Longevity Research and What It Shows

Epithalon (Ala-Glu-Asp-Gly, AEDG) is a synthetic tetrapeptide originally derived from pineal gland extract with published human research from Vladimir Khavinson's group at the Saint Petersburg Institute of Bioregulation and Gerontology, including cohort studies reporting age-related biomarker improvements and extended survival in elderly populations.

epithalon clinical evidenceepithalon human researchepithalon Khavinson studyepithalon telomerase researchAEDG peptide human trialsepithalon longevity research
Read Guide
Advanced12 min read

Longevity Peptides Ranked: Evidence, Mechanisms, and Research Use Cases

A structured ranking of the five most-studied longevity research compounds - NAD+, MOTS-c, SS-31, Epithalon, and GHK-Cu - ranked by evidence quality, mechanistic specificity, aging hallmark coverage, and translational potential for human research.

longevityagingpeptidesmitochondriaanti-agingmitochondrial peptidesresearch peptides
Read Guide
📋
Advanced11 min read

TB-500 and Thymosin Beta-4 Clinical Evidence: What the Human Trial Data Shows

Thymosin Beta-4, the full-length protein of which TB-500 is an active synthetic fragment, has a substantial published clinical trial record spanning dry eye disease, cardiac repair, and peripheral artery disease - making it one of the few research peptides with Phase 2 human clinical data from multiple independent indications.

TB-500tissue repairrecoveryhealingThymosin Beta-4clinical evidencemusculoskeletal
Read Guide
💪
Advanced11 min read

Recovery Peptides Ranked: BPC-157, TB-500, GHK-Cu, and Growth Hormone Secretagogues

A structured ranking of the five most-studied tissue repair and recovery research compounds - BPC-157, TB-500, GHK-Cu, and the GH secretagogue pair CJC-1295/Ipamorelin - evaluated on evidence volume, mechanistic specificity, tissue applicability, and human translational data.

recovery peptides rankedbest peptide for recoveryBPC-157 vs TB-500 rankedpeptide tissue repair comparisontop recovery peptides researchBPC-157 TB-500 GHK-Cu comparison
Read Guide
⚖️
Advanced11 min read

Weight Loss Peptides Ranked: Retatrutide, Semaglutide, Tirzepatide, and MOTS-c

A structured ranking of the most-studied weight loss and metabolic research compounds - retatrutide, tirzepatide-class agents, MOTS-c, tesamorelin, and NAD+ - ranked by published weight loss efficacy data, human trial evidence, and mechanistic differentiation.

weight loss peptides rankedbest peptide for weight loss researchretatrutide vs semaglutide vs tirzepatideGLP-1 peptide comparisontop metabolic peptides researchretatrutide MOTS-c weight loss
Read Guide
💪
Intermediate10 min read

Ipamorelin + CJC-1295 Stack: The Research Behind the Most Popular GH Secretagogue Combination

Ipamorelin and CJC-1295 are the two most researched growth hormone secretagogues in the published literature, and they are almost always studied together because their mechanisms are genuinely complementary: CJC-1295 extends GH pulse duration while ipamorelin triggers clean, selective GH release without spiking cortisol or prolactin.

ipamorelin cjc 1295 stackipamorelin cjc-1295 dosingCJC-1295 ipamorelin resultsgrowth hormone secretagogue stackipamorelin protocolCJC-1295 research guide
Read Guide
Intermediate10 min read

BPC-157 and TB-500 Stack: How the Two Best Repair Peptides Work Together

BPC-157 and TB-500 are the two most studied repair peptides in preclinical research, and they are frequently combined because their mechanisms address different stages of the tissue repair cascade: BPC-157 drives angiogenesis and vascular repair, while TB-500 accelerates cell migration and anti-inflammatory resolution.

BPC-157 TB-500 stackBPC-157 TB-500 protocolBPC-157 TB-500 togetherpeptide healing stackBPC-157 TB-500 dosingbest healing peptide stack
Read Guide
💪
Intermediate10 min read

Peptides for Muscle Growth Research: GH Secretagogues, IGF-1, and Repair Peptides Compared

The most studied peptides in muscle biology research operate through two distinct pathways: GH secretagogues (ipamorelin, CJC-1295) work indirectly through the GH/IGF-1 axis to stimulate satellite cell activation and protein synthesis, while repair peptides (BPC-157, TB-500) work directly on muscle tissue through angiogenesis and cell migration mechanisms.

peptides for muscle growthbest peptide for muscle buildingpeptides muscle researchipamorelin muscle researchBPC-157 muscle researchgrowth hormone peptide muscle
Read Guide
📊
Intermediate9 min read

Retatrutide Results: What Phase 2 Data Shows About Weight Loss Timeline and Outcomes

The retatrutide Phase 2 NEJM trial published in 2023 showed 24.2% mean body weight reduction at 48 weeks in the highest-dose group (12 mg weekly), making it the largest weight loss ever reported for a pharmacological compound in a randomized controlled trial at that time.

retatrutide resultsretatrutide weight loss resultshow much weight can you lose on retatrutideretatrutide before and afterretatrutide timelineretatrutide phase 2 results weight loss
Read Guide
Intermediate10 min read

NAD+ and Anti-Aging: What the Research Actually Shows in 2026

NAD+ does have legitimate anti-aging research support, but the evidence is more specific than the popular narrative suggests: human trials confirm NAD+ precursors raise tissue NAD+ levels and improve certain metabolic parameters, while lifespan extension remains demonstrated in animals but unproven in humans.

NAD+longevityagingmitochondriasirtuinmitochondrial peptidesmetabolic health
Read Guide
🧠
Intermediate10 min read

Selank for Anxiety: The Research Behind the Most Studied Anxiolytic Peptide You Have Never Heard Of

Selank is a synthetic heptapeptide analog of Tuftsin (Thr-Lys-Pro-Arg) that has been registered as an anxiolytic pharmaceutical in Russia since 2009, with published clinical data showing benzodiazepine-comparable anxiolytic effects without sedation, tolerance development, or withdrawal syndrome.

Selankanxietycognitiveneuroprotectionbrain healthnootropicBDNF
Read Guide
⚖️
Intermediate9 min read

Retatrutide vs Ozempic: How the New Triple Agonist Compares to the Most Famous Weight Loss Drug

Retatrutide produced 24.2% mean weight loss at 48 weeks versus semaglutide (Ozempic/Wegovy) showing 14.9% at 68 weeks, and the key difference is not just magnitude: retatrutide adds two more receptor targets (GIP and glucagon) on top of the GLP-1 receptor that Ozempic uses exclusively.

retatrutide vs ozempicretatrutide vs semaglutideretatrutide ozempic comparisonis retatrutide better than ozempicnew weight loss drug vs ozempicretatrutide vs wegovy
Read Guide
💉
Beginner8 min read

How to Reconstitute Peptides: Step-by-Step Guide for Research Use

To reconstitute a lyophilized peptide, add bacteriostatic water directly to the vial using a syringe, let it dissolve without shaking, and store the reconstituted solution at 4 degrees Celsius. The entire process takes under 2 minutes and the quality of your reconstitution directly affects the validity of your research results.

how to reconstitute peptideshow to mix peptides for researchbacteriostatic water for peptidespeptide reconstitution guidehow to prepare BPC-157lyophilized peptide mixing
Read Guide
🧠
Intermediate9 min read

Cerebrolysin vs Semax: A Head-to-Head Comparison of the Two Most Studied Nootropic Peptides

Cerebrolysin delivers exogenous neurotrophic factors (BDNF, NGF, CNTF, GDNF) directly to brain tissue, while Semax upregulates the brain’s own endogenous BDNF production. Both work, but through fundamentally different strategies, and which is better depends entirely on the research question.

cerebrolysin vs semaxcerebrolysin semax comparisonbest nootropic peptide researchcerebrolysin or semaxsemax vs cerebrolysin BDNFnootropic peptide comparison
Read Guide
🌱
Intermediate10 min read

BPC-157 for Gut Health: The Research Behind the Most Studied GI Repair Peptide

BPC-157 (Body Protection Compound-157) is a synthetic 15-amino acid peptide derived from a protein found in human gastric juice, and its most extensive and consistent research evidence is in gastrointestinal repair, with published studies spanning gastric ulcers, inflammatory bowel disease, intestinal fistulas, and leaky gut models across 30+ years.

BPC-157 gut healthBPC-157 leaky gut researchBPC-157 IBD researchBPC-157 gastrointestinalBPC-157 intestinal repairBPC-157 gut healing
Read Guide
Intermediate9 min read

GHK-Cu for Skin: What the Research Actually Shows About Copper Peptides and Anti-Aging

GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) has more published human clinical evidence for skin anti-aging than any other research peptide, including multiple randomized controlled trials showing measurable improvements in skin thickness, wrinkle depth, elasticity, and collagen synthesis.

GHK-Cu skin benefitsGHK-Cu anti-aging researchcopper peptide skin researchGHK-Cu wrinkles researchGHK-Cu collagen researchbest peptide for skin anti-aging
Read Guide
💡
Intermediate9 min read

Peptides for Brain Fog: What the Research Shows About Cognitive Clarity Compounds

Brain fog in research contexts involves three distinct mechanisms: neuroinflammation (elevated cytokines impairing synaptic function), BDNF and neurotrophin deficits (reducing synaptic plasticity), and mitochondrial dysfunction (ATP shortage in neurons). Different peptides address different mechanisms, which is why matching the compound to the mechanism matters.

peptides for brain fogbest peptide for brain fogsemax brain fogselank brain fogcerebrolysin brain fognootropic peptides cognitive clarity
Read Guide
🗂️
Deep Dive14 min read

Russian Peptide Bioregulators: The Complete English Guide to Khavinson's System

Vladimir Khavinson and the Saint Petersburg Institute of Bioregulation and Gerontology have produced one of the most comprehensive peptide aging research programs in scientific history, with 800+ published papers, clinical use in thousands of patients, and a systematic theory of organ-specific short peptide bioregulators that remains almost entirely unknown to English-speaking researchers.

Russian peptide bioregulatorsKhavinson peptide researchshort peptide bioregulatorspeptide bioregulation agingEpithalon Thymalin Vilon CortexinSoviet anti-aging research
Read Guide
🧠
Deep Dive10 min read

Cortexin: The Russian Neuropeptide Used in Stroke Care That Western Researchers Have Never Heard Of

Cortexin is a polypeptide mixture extracted from bovine cerebral cortex that has been a registered pharmaceutical in Russia since 1982, used in neurological care including stroke, traumatic brain injury, epilepsy, and cognitive decline. A 2019 randomized comparison with Cerebrolysin in embolic stroke showed both produced significant neurological recovery. English-language coverage of Cortexin is almost nonexistent.

Cortexin neuropeptide researchCortexin peptide strokeRussian neuropeptide drugsCortexin vs Cerebrolysincortical peptide mixture neurologicalCortexin cognitive research
Read Guide
🧬
Deep Dive9 min read

Vilon (KE Dipeptide): The Russian Immune Bioregulator That Modulates SIRT1 and Telomerase

Vilon is a Lys-Glu (KE) dipeptide developed as an immune system bioregulator by Khavinson's group, with published research showing it modulates SIRT1, PARP1, TERT, FOXO1, and NFkB gene expression in aging human mesenchymal stem cells, directly connecting this two-amino-acid peptide to the core longevity gene network.

Vilon KE dipeptide researchLys-Glu peptide agingKE peptide SIRT1 researchRussian peptide bioregulator immuneVilon telomerase researchdipeptide longevity gene regulation
Read Guide
🌍
Education11 min read

Soviet Peptide Research: The Decades of Science the West Almost Missed

The Soviet Union ran one of the most extensive peptide research programs in scientific history, motivated by military interest in performance enhancement and longevity, and produced clinically registered drugs (Semax, Selank, Cortexin, Cerebrolysin-equivalents) still in use today that Western researchers know almost nothing about.

Soviet peptide research historyRussian peptide science historyKhavinson Soviet longevity researchRussian neuropeptides historyCold War peptide scienceSoviet anti-aging research programs
Read Guide
🌏
Advanced10 min read

Cerebrolysin in Asian Clinical Trials: The Data Western Reviews Don't Cover

Cerebrolysin has been studied in dozens of Asian randomized controlled trials across China, South Korea, and Taiwan involving thousands of patients, with findings that substantially supplement the Eastern European evidence base and address specific questions about vascular dementia and post-stroke cognitive impairment that Western reviews have largely missed.

Cerebrolysin Asian clinical trialsCerebrolysin China Korea evidenceCerebrolysin dementia Asian dataCerebrolysin stroke Asian researchCerebrolysin evidence review Asianeuropeptide research Asia
Read Guide
🛁
Deep Dive10 min read

Thymalin: The Soviet Thymic Peptide That Restores Immune Function and Extends Lifespan in Published Research

Thymalin is a polypeptide mixture from bovine thymus developed at the Military Medical Academy in Leningrad, with published rodent studies showing 20-40% mean lifespan extension and human cohort data (PMID 15350912) showing improved 6-year survival when combined with Epithalon in elderly subjects.

Thymalin thymic peptide researchthymus peptide anti-agingThymalin immune aging Russian researchthymic peptide lifespan extensionSoviet thymus bioregulatorimmune aging peptide research
Read Guide
📈
Intermediate9 min read

Ipamorelin Results: What Published Research Shows About Timeline, Dose-Response, and Body Composition

Published ipamorelin research shows a clean GH pulse peaking at 15-30 minutes post-injection, IGF-1 elevation at 12-24 hours, and statistically significant body composition differences (10-20% lean mass gain, 15-25% fat mass reduction) emerging at 6-8 weeks in aged rodent models, with zero cortisol, prolactin, or ACTH co-stimulation.

ipamorelin results researchipamorelin before after research dataipamorelin IGF-1 elevation timelineipamorelin body composition researchhow long does ipamorelin take to workipamorelin vs GHRP-6 selectivity
Read Guide
⚖️
Education8 min read

Are Research Peptides Legal? A Clear Guide to the Regulatory Status of Peptide Research Compounds

Research peptides in the United States are legal to purchase and possess for legitimate research and educational purposes. They are not controlled substances under the DEA, not approved drugs regulated for human therapeutic use, and not dietary supplements, occupying a specific regulatory space as research compounds available for in vitro and preclinical research.

are research peptides legalpeptide research legal statusBPC-157 legalresearch peptide laws USare peptides legal to buyresearch chemical peptide regulations
Read Guide
🧬
Deep Dive11 min read

SHMOOSE: The Mitochondrial Microprotein Science Just Discovered

SHMOOSE is a mitochondrial-encoded microprotein from the Humanin and MOTS-c family with only 6 published studies and new 2026 data linking it to heart protection and preferential loss in the aging brain.

SHMOOSE mitochondrial microprotein researchmitochondrial derived peptides agingSHMOOSE Humanin MOTS-c comparisonmitochondrial microprotein cardiovascularmitochondriaaginglongevitymitochondrial peptidesneuroprotectionbrain health
Read Guide
⚖️
Advanced14 min read

Semaglutide Plateau Research: Why Weight Loss Slows Over Time

Weight loss on semaglutide typically plateaus between weeks 48 and 68 in published STEP trial data, even when adherence remains high. The biological mechanisms behind this plateau involve GLP-1 receptor downregulation, adaptive thermogenesis, and the body's homeostatic defense of its energy set point. Understanding these mechanisms is essential for researchers studying next-generation GLP-1-class compounds like retatrutide, which adds glucagon receptor agonism specifically to address thermogenic limitations.

semaglutide plateauozempic plateauGLP-1 plateauweight loss plateau semaglutidewhat happens when semaglutide stops workingretatrutide after semaglutideadaptive thermogenesismetabolic compensation
Read Guide
🔬
Advanced13 min read

Tirzepatide Mechanism: GLP-1, GIP, and Dual Agonist Research Explained

Tirzepatide is a dual GLP-1/GIP receptor agonist: a single synthetic peptide engineered to activate both glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptors simultaneously. The SURMOUNT-1 trial demonstrated 22.5% mean body weight reduction at 72 weeks, exceeding published semaglutide outcomes, largely attributed to the GIP receptor component adding mechanisms beyond what GLP-1 alone provides. Understanding tirzepatide's mechanism is foundational for researchers studying the progression from GLP-1 mono-agonism to retatrutide's triple agonism.

tirzepatide mechanismtirzepatide GLP-1 GIPtirzepatide vs semaglutide mechanismdual agonist mechanismGIP receptor agonismtirzepatide researchSURMOUNT trialincretin
Read Guide
🧠
Advanced12 min read

Dihexa Research Protocol: Experimental Design Considerations From Published Studies

Dihexa (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide) is a heptamembranous hexapeptide derived from angiotensin IV, developed at Washington State University. It is studied for its potent activation of the HGF/c-Met receptor pathway, which regulates synaptogenesis and dendritic spine density. No established human dosing protocol exists; this article reviews experimental design considerations from published animal model literature only. Dihexa is a research compound with no human clinical trial data.

Dihexa dosageDihexa protocolDihexa research protocolDihexa cognitive researchDihexa HGF c-MetDihexa dose rangeHGF receptor agonistsynaptogenesis peptide
Read Guide
🧠
Advanced13 min read

Semax vs Selank Research Compared: Mechanisms, Neuroregulation, and Cognitive Targets

Semax and Selank are both Russian-developed peptides with clinical registration histories in Russia, but they work through fundamentally different mechanisms. Semax is an ACTH 4-10 fragment analog that upregulates BDNF and modulates dopaminergic/serotonergic signaling, making it more stimulatory and cognition-oriented. Selank is a tuftsin analog that modulates GABA-A receptors and regulates anxiety-related pathways, making it more calming and anxiolytic. Published research suggests they are complementary rather than competing compounds. This article compares their mechanisms, clinical histories, and research applications side by side.

Semax vs SelankSemax Selank comparisonnootropic peptide comparisonSemax researchSelank researchRussian nootropic peptidesBDNF peptideanxiolytic peptide
Read Guide
🧠
Advanced14 min read

Peptides for TBI Research: Cerebrolysin, Neurotrophic Signaling, and Neurorecovery Models

Of the peptide compounds studied in traumatic brain injury research, Cerebrolysin has the strongest clinical evidence base, with multiple randomized controlled trials in both TBI and ischemic stroke. The biological rationale for peptide intervention in TBI centers on the secondary injury cascade: after primary mechanical trauma, a cascade of excitotoxicity, oxidative stress, inflammation, and apoptosis continues to destroy neurons over hours to days. Neurotrophic factors like BDNF and NGF play critical roles in limiting this secondary damage, which is why neurotrophic peptide compounds have attracted sustained research interest in this field.

peptides for TBItraumatic brain injury peptide researchCerebrolysin TBIneurotrophic peptidesbrain injury peptide researchTBI neurorecoveryBDNF TBIneuroprotection peptide
Read Guide
🧬
Advanced13 min read

Nootropic Peptide Stack Research: Mapping Mechanisms Across Semax, Selank, Cerebrolysin, NAD+, and Dihexa

The five most-studied cognitive research peptides, Semax, Selank, Cerebrolysin, NAD+, and Dihexa, each target distinct nodes in the cognitive biology network. Semax drives BDNF upregulation. Selank modulates GABA-A and the anxiety axis. Cerebrolysin delivers exogenous neurotrophic factors. NAD+ fuels neuronal mitochondria. Dihexa activates HGF/c-Met-mediated synaptogenesis. Their mechanistic non-redundancy is what makes multi-compound cognitive research designs scientifically interesting, though this article is a mechanism-mapping guide for research context only, not a protocol for unsupervised use.

nootropic peptide stackcognitive peptide stackSemax Selank Cerebrolysin NAD+ Dihexabest nootropic peptides researchpeptide cognitive research designcognitive peptide mechanismsbrain peptide research
Read Guide
🔬
Advanced13 min read

BPC-157 for Tendon Research: Healing Models, Angiogenesis, and Injury Repair Mechanisms

BPC-157 (body protection compound-157) is studied more extensively in tendon and ligament models than any other single research peptide. Its primary mechanisms in connective tissue research center on VEGF-driven angiogenesis in typically avascular tendon tissue and fibroblast proliferation and collagen synthesis stimulation. Published research from the Zagreb group and other laboratories has examined BPC-157 in Achilles tendon transection, quadriceps injury, and ligament tear models, consistently observing accelerated recovery metrics relative to controls. This article reviews this literature for research context.

BPC-157 tendonBPC-157 tendon healingBPC-157 ligament researchBPC-157 injury researchBPC-157 athletestendon peptide researchBPC-157 angiogenesistendon healing peptide
Read Guide
🔬
Advanced12 min read

KPV and Crohn's Research: Inflammation, IBD Models, and Gut Barrier Signaling

KPV (Lys-Pro-Val) is a C-terminal tripeptide fragment of alpha-MSH (alpha-melanocyte-stimulating hormone), studied for gut-specific anti-inflammatory signaling via MC3R and MC5R melanocortin receptor subtypes. Unlike full alpha-MSH, KPV targets receptor subtypes expressed in intestinal epithelium and immune cells without engaging MC1R (which mediates skin pigmentation). Published IBD model research in TNBS- and DSS-induced colitis demonstrates significant reduction in inflammatory markers, improved gut barrier integrity, and attenuated mucosal damage in KPV-treated animals.

KPV Crohn'sKPV IBDKPV gut inflammationKPV peptide researchKPV inflammatory bowel diseasemelanocortin gutgut barrier peptideintestinal inflammation research
Read Guide
💜
Advanced13 min read

SS-31 Heart Failure Research: Mitochondrial Peptide Mechanisms and Clinical Evidence

SS-31 (elamipretide, D-Arg-Dmt-Lys-Phe-NH2) is the only mitochondria-targeting peptide to reach Phase 2 and Phase 3 clinical trials. Its mechanism centers on cardiolipin stabilization in the inner mitochondrial membrane (IMM), preserving electron transport chain structure and reducing reactive oxygen species production. In heart failure, where mitochondrial dysfunction is a primary driver of contractile impairment, this mechanism has been studied in multiple clinical trials, including PROGRESS-HF and VITALITY-HFpEF conducted by Stealth BioTherapeutics.

SS-31 heart failureelamipretide heart failureSS-31 mitochondriamitochondrial peptide researchSS-31 clinical trialselamipretide researchcardiolipin SS-31HFpEF research
Read Guide
🔬
Advanced13 min read

MOTS-c Diabetes Research: AMPK, Insulin Sensitivity, and Metabolic Signaling

MOTS-c (mitochondrial open reading frame of the 12S rRNA-c) is a 16-amino acid peptide encoded in the mitochondrial genome. Published Lee laboratory research demonstrates MOTS-c activates AMPK (adenosine monophosphate-activated protein kinase) in skeletal muscle, driving GLUT4 translocation and enhancing glucose uptake. These mechanisms overlap with exercise-induced insulin sensitization, supporting MOTS-c's classification as an "exercise mimetic" peptide. MOTS-c levels decline with age and are reduced in type 2 diabetes populations in published cross-sectional data.

MOTS-c diabetesMOTS-c insulin sensitivityMOTS-c AMPKmitochondrial peptide diabetesMOTS-c metabolic researchMOTS-c insulin resistanceexercise mimetic peptidemitochondrial derived peptide
Read Guide
🧠
Advanced14 min read

Cerebrolysin for TBI and Stroke Research: Neurorecovery Evidence and Mechanisms

Cerebrolysin is a porcine brain-derived hydrolysate containing small peptide fragments and free amino acids from BDNF, NGF, GDNF, and CNTF. It is the only peptide preparation with published Phase 2/3 RCT data in both traumatic brain injury (TBI) and ischemic stroke. Evidence is strongest in Asian trial networks; the large European/American ICTUS-L trial produced mixed results. This article reviews the clinical evidence hierarchy, neurotrophic mechanisms, and what the regional data differences may reflect.

Cerebrolysin TBICerebrolysin strokeCerebrolysin brain injuryCerebrolysin neurorecoveryCerebrolysin clinical trialsCerebrolysin evidence reviewICTUS trialneurotrophic stroke
Read Guide
🔬
Advanced12 min read

Peptides for PCOS Research: Metabolic Dysfunction, Insulin Signaling, and Inflammation

PCOS (polycystic ovary syndrome) is primarily a metabolic-endocrine condition with insulin resistance as a central driver. GLP-1 receptor agonists have the most published clinical evidence in PCOS of any peptide-class compound, demonstrating weight reduction, insulin sensitization, and androgen normalization. MOTS-c's AMPK mechanism, SS-31's mitochondrial support in ovarian tissue, and anti-inflammatory research compounds represent mechanistically distinct angles on PCOS biology. This article maps peptide mechanisms to PCOS pathophysiology for research context.

peptides for PCOSPCOS peptide researchinsulin resistance PCOS peptidesMOTS-c PCOSGLP-1 PCOS researchPCOS metabolic researchGLP-1 agonist PCOSAMPK PCOS
Read Guide
🔬
Advanced13 min read

Peptides for Menopause Research: NAD+, GHK-Cu, MOTS-c, and Aging Pathways

Menopause drives multiple simultaneous biological shifts: mitochondrial function declines, metabolism slows, skin matrix degrades, and inflammation increases. Research on NAD+, GHK-Cu, MOTS-c, and SS-31 is relevant to menopause biology because these compounds' mechanisms intersect with the pathways most affected by hormonal transition. This article reviews those mechanistic intersections for research context only. No compound discussed here is studied as a menopause treatment or hormonal replacement. None alter sex hormone levels.

peptides for menopausemenopause peptide researchNAD+ menopauseGHK-Cu menopause skinMOTS-c menopause metabolismhormonal aging peptidesperimenopause researchestrogen aging biology
Read Guide
Advanced13 min read

GHK-Cu Hair Loss Research: Copper Peptides, Follicle Biology, and Scalp Remodeling

GHK-Cu (glycyl-L-histidyl-L-lysine copper(II) complex) has the most published research of any copper peptide in hair follicle biology. Originally described by Loren Pickart as a naturally occurring human plasma tripeptide that declines with aging, GHK-Cu has been shown in published cell and animal studies to stimulate dermal papilla cell proliferation, upregulate VEGF in follicle vasculature, and activate thousands of follicle-relevant genes. Published follicle model data consistently shows pro-growth signals, though large-scale human clinical RCT data is limited.

GHK-Cu hair losscopper peptide hair growthGHK-Cu hair researchpeptides for hair losscopper peptide scalphair follicle peptide researchdermal papilla peptideandrogenic alopecia research
Read Guide
Advanced12 min read

TB-500 Hair Growth Research: Thymosin Beta-4, Follicle Biology, and Tissue Remodeling

TB-500 (Ac-SDKP, the active tetrapeptide fragment of thymosin beta-4) is an actin-sequestering and cell migration-promoting peptide. Published research from the Goldstein and Philp laboratories demonstrated that full thymosin beta-4 reactivates dormant hair follicle bulge stem cells and promotes anagen re-entry. The 2004 Philp et al. Nature/Mech Dev paper on thymosin beta-4 in hair follicle development remains a landmark in peptide hair biology. TB-500 itself is the Ac-SDKP fragment, not full thymosin beta-4, and this distinction matters for research context.

TB-500 hair growththymosin beta-4 hair follicleTB-500 hair losspeptides for hair growth researchthymosin beta 4 skin hairhair follicle stem cellAc-SDKP hairanagen activation
Read Guide
🔬
Advanced13 min read

Peptide Bioavailability Research: Subcutaneous, Oral, IV, and Intranasal Delivery Compared

The route of administration is one of the most consequential variables in peptide research design. Bioavailability (the fraction of an administered dose reaching systemic circulation in active form) varies dramatically by route: subcutaneous injection achieves 80-100% for most peptides; oral delivery achieves less than 5% for most; intranasal delivery achieves 1-50% depending on the compound, with direct olfactory access to the CNS as a unique pharmacokinetic feature. Understanding these differences is essential for designing peptide research studies and interpreting published data across different administration routes.

peptide bioavailabilitysubcutaneous vs oral peptidespeptide absorptionintranasal peptide bioavailabilityIV peptide deliverypeptide pharmacokineticspeptide half-lifeblood brain barrier peptide
Read Guide
🔋
Advanced13 min read

NAD+ Addiction Research: Withdrawal Models, Energy Metabolism, and Clinical Interest

Addiction biology fundamentally involves cellular energy metabolism dysregulation. Chronic substance use depletes NAD+ (nicotinamide adenine dinucleotide) through PARP overactivation, mitochondrial stress, and metabolic disruption. The NAD+/NADH ratio in neurons is central to normal dopamine synthesis and neurotransmitter function. Published clinical research has examined IV NAD+ in withdrawal settings, with early data suggesting reduced withdrawal symptom burden in open-label and observational designs. This article reviews the published evidence for research context. This is not a recommendation for personal addiction treatment.

NAD+ addictionNAD+ withdrawalNAD IV addiction researchNAD+ alcohol withdrawalNAD+ substance use researchNAD+ opioid withdrawalnicotinamide adenine dinucleotide addictionNAD+ brain energy
Read Guide
🌙
Advanced11 min read read

DSIP Research: Delta Sleep-Inducing Peptide, Sleep Architecture, and Neuroregulation

DSIP (delta sleep-inducing peptide) is a nine-amino-acid peptide first isolated from rabbit thalamus in 1974. Unlike pharmacological sleep agents that force sedation, DSIP appears to modulate the neuroendocrine environment in which sleep occurs. Fifty years of research have produced a nuanced and sometimes contradictory body of evidence. This article reviews what the published literature actually shows.

DSIP sleepdelta sleep-inducing peptideDSIP researchDSIP peptidesleep peptide researchDSIP nonapeptide
Read Guide
🌙
Advanced12 min read read

Peptides for Sleep Research: DSIP, Selank, GHK-Cu, and Neuroregulatory Mechanisms

Sleep biology involves multiple interacting regulatory systems: circadian clocks, adenosine accumulation, GABA inhibition, neuroendocrine rhythms, and mitochondrial energy supply. Several research peptides have been studied in these systems through distinct mechanisms. This article maps the published research across five compounds and compares what the evidence actually shows.

peptides for sleepsleep peptide researchDSIP sleepSelank sleeppeptide sleep architecturesleep research peptides
Read Guide
🧠
Advanced11 min read read

BPC-157 Dopamine Research: Neurotransmitter Modulation, Receptor Effects, and CNS Models

BPC-157 is best known for musculoskeletal repair research, but a substantial and underappreciated body of published work examines its activity in dopaminergic and serotonergic systems. This review summarizes what the published literature shows about BPC-157 in CNS models, with particular attention to the dopamine receptor density research and the NO pathway mechanism in neural tissue.

BPC-157 dopamineBPC-157 neurotransmitterBPC-157 CNSBPC-157 brain researchBPC-157 serotoninBPC-157 neurological research
Read Guide
🧠
Advanced12 min read read

Cerebrolysin and Parkinson's Research: Neurotrophic Mechanisms and Neuroprotection Evidence

Parkinson's disease is fundamentally a condition of dopaminergic neuron loss in the substantia nigra. Neurotrophic factors, particularly GDNF, are the most potent known protectors of these neurons. Cerebrolysin contains low-molecular-weight neuropeptides with GDNF-like activity. This review examines what published preclinical and limited clinical evidence shows about Cerebrolysin in Parkinson's research models.

Cerebrolysin Parkinson'sCerebrolysin Parkinson's diseaseneuroprotection Parkinson's peptideGDNF Parkinson's researchCerebrolysin dopamineneurotrophic Parkinson's
Read Guide
🌊
Advanced11 min read read

Selank, Cortisol, and HPA Axis Research: Stress Biology and Neuroregulation

Selank is a synthetic heptapeptide developed from the immune peptide tuftsin and registered in Russia as an anxiolytic. Its stress biology research is distinct from standard pharmacological anxiolytics: Selank modulates GABA-A function and BDNF expression without benzodiazepine-type sedation, dependency, or cognitive impairment. This review examines the published evidence on Selank's interactions with the HPA axis and cortisol-related stress signaling.

Selank cortisolSelank HPA axisSelank stress researchSelank anxiety cortisolHPA axis peptidetuftsin stress research
Read Guide
🔬
Advanced10 min read read

BPC-157 Liver Research: Hepatoprotective Mechanisms and Published Model Data

BPC-157 originated from research into gastric mucosal protection. The connection to liver biology follows logically: the portal circulation links the gastrointestinal tract directly to the liver, and the same cytoprotective mechanisms that protect gastric mucosa extend to hepatic tissue in published models. This review covers what the published literature shows about BPC-157 in hepatotoxicity, portal hypertension, and fibrosis models.

BPC-157 liverBPC-157 hepatoprotectiveBPC-157 liver researchBPC-157 hepaticliver peptide researchBPC-157 cirrhosis
Read Guide
🦴
Advanced11 min read read

BPC-157 Bone Healing Research: Fracture Models, Angiogenesis, and Skeletal Repair

Bone healing is fundamentally a vascular process: adequate blood supply to the fracture site is the single most important determinant of fracture healing speed and quality. BPC-157's VEGF-driven angiogenic mechanism makes it mechanistically well-suited to bone repair research. This review covers what published fracture models and mechanistic studies show.

BPC-157 bone healingBPC-157 fracture researchBPC-157 bone repairbone healing peptideBPC-157 skeletal researchbone fracture peptide research
Read Guide
❤️
Advanced12 min read read

TB-500 Cardiac Research: Thymosin Beta-4, Heart Repair, and Cardioprotection

Thymosin beta-4, the source protein from which TB-500's active fragment (Ac-SDKP) is derived, was identified as a key cardiac regeneration factor in landmark 2004 research showing it reactivated embryonic heart development genes in adult cardiac tissue after injury. This review covers the published cardiac biology of thymosin beta-4 and TB-500, from cardiomyocyte protection to cardiac stem cell activation.

TB-500 cardiacthymosin beta-4 heartTB-500 heart researchthymosin beta-4 cardiaccardioprotection peptideTB-500 cardioprotection
Read Guide
🔬
Advanced12 min read read

Tesamorelin Visceral Fat Research: GHRH Analog, GH Axis, and Lipodystrophy Evidence

Tesamorelin (brand name Egrifta) is the only FDA-approved synthetic GHRH analog. Its approval was based on Phase 3 randomized controlled trial data demonstrating significant visceral adipose tissue reduction in HIV patients with antiretroviral-associated lipodystrophy. This review covers the mechanism, the clinical evidence, and the post-approval research interest in broader metabolic applications.

tesamorelin visceral fattesamorelin researchtesamorelin GHRHGHRH analog fattesamorelin HIV lipodystrophyGH axis visceral fat
Read Guide
🔋
Advanced13 min read read

NAD+ and Sirtuin Research: Deacylase Pathways, Aging Biology, and Metabolic Regulation

Sirtuins are NAD+-dependent protein deacylases that cannot function without NAD+ as an obligate cosubstrate. This single biochemical fact links cellular NAD+ levels directly to gene regulation, DNA repair, mitochondrial function, and metabolic adaptation. Understanding the NAD+-sirtuin axis is foundational to understanding the biology of aging and what NAD+ supplementation research is actually targeting.

NAD+ sirtuinsSIRT1 NAD+NAD+ aging mechanismsirtuins researchNAD+ sirtuin pathwayHDAC NAD+ research
Read Guide
🛡️
Advanced13 min read read

Peptides for Autoimmune Research: Inflammation Pathways, Regulatory Mechanisms, and Published Evidence

Autoimmune disease involves immune system dysregulation across multiple axes: Th1/Th2/Th17 balance disruption, regulatory T-cell failure, barrier integrity loss, and mitochondrial inflammasome activation. Several research peptides have published activity in immune regulation models through these distinct mechanisms. This review maps the immunological research for five compounds and what the evidence actually shows.

peptides for autoimmuneautoimmune peptide researchKPV autoimmuneBPC-157 immunemelanocortin autoimmunepeptide immunomodulation
Read Guide
Advanced12 min read read

MOTS-c Exercise Research: Mitochondrial Exercise Mimetic, AMPK Activation, and Physical Performance Models

MOTS-c (mitochondrial open reading frame of the 12S rRNA type-c) was described as an "exercise mimetic" in the original published literature by the Kim and Cohen lab. It activates AMPK through a novel LARS1-dependent pathway, recapitulates multiple exercise-induced metabolic programs, and published animal data shows it improves physical performance and reduces age-related exercise capacity decline. This review covers what the published literature actually shows about this mechanism.

MOTS-c exerciseMOTS-c exercise mimeticMOTS-c physical performanceMOTS-c AMPK exercisemitochondrial peptide exerciseMOTS-c skeletal muscle
Read Guide
📈
Intermediate9 min read

CJC-1295 w/DAC: The Long-Acting GHRH Analog and What Published Research Shows

CJC-1295 with DAC is a synthetic analog of growth hormone-releasing hormone (GHRH) designed to overcome a fundamental pharmacological problem: natural GHRH has a half-life of less than four minutes in circulation before plasma proteases degrade it. The Drug Affinity Complex (DAC) modification solves this by chemically linking the peptide to a maleimide group that binds reversibly and covalently to the cysteine-34 residue of serum albumin. Since albumin circulates for roughly 19 days, the CJC-1295/albumin complex is protected from protease degradation - extending the functional half-life from minutes to days. The result is the most studied long-acting GHRH analog in the published literature, with a 2006 human clinical trial that remains the reference dataset for GHRH analog pharmacokinetics.

cjc-1295 daccjc-1295 with daccjc 1295 dac half lifeGHRH analoggrowth hormone researchCJC-1295 ipamorelin
Read Guide
🧮
Beginner9 min read

Peptide Reconstitution Calculator: How to Get the Right Syringe Mark Every Time

A peptide reconstitution calculator solves one specific problem: how much bacteriostatic water to add to a lyophilized peptide vial, and what syringe mark to draw for each dose. The math is not complicated, but even a small error changes the actual amount of compound per dose significantly. This guide walks through the full calculation, shows worked examples for the most common research compounds, and flags the mistakes that most researchers encounter early on.

peptide reconstitution calculatorpeptide calculatorhow to calculate peptide doseBPC-157 reconstitution calculatorpeptide syringe markspeptide dosage calculatorbacteriostatic water calculatorinsulin syringe peptide math
Read Guide
🧪
Beginner6 min read

How to Use the Blackwell BioLabs Peptide Calculator: Step-by-Step Tutorial

The Blackwell BioLabs peptide calculator is a free tool that takes the guesswork out of peptide reconstitution. You tell it what compound you have, how much is in the vial, how much bacteriostatic water you want to add, and what dose you need. It tells you exactly which syringe mark to draw to, how many doses your vial will yield, and what each dose costs. This tutorial walks through every screen of the calculator, then shows you how to save your results to your Protocol Stack and track your research schedule from your account dashboard.

how to use peptide calculatorpeptide calculator tutorialpeptide reconstitution calculator guidepeptide protocol trackerhow to reconstitute peptidespeptide syringe markspeptide dosing calculatorpeptide protocol stack
Read Guide
⚖️
Advanced11 min read

Tirzepatide vs Semaglutide: What the SURMOUNT-5 Head-to-Head Trial Actually Shows

For years, comparing tirzepatide and semaglutide meant lining up two separate trials with different populations, durations, and dose schedules - an indirect exercise that could suggest a ranking but never prove one. SURMOUNT-5, published in the New England Journal of Medicine in 2025, changed that. It was the first large randomized trial to put the two compounds head to head in the same population, and the published data reported that tirzepatide produced a mean body weight reduction of approximately 20.2% at 72 weeks versus approximately 13.7% for semaglutide, an absolute difference of about 6.5 percentage points favoring tirzepatide. This article breaks down what SURMOUNT-5 measured, how the two compounds compared on weight, waist circumference, and gastrointestinal tolerability, and - just as importantly - what a single open-label trial cannot tell you. All compounds discussed are sold strictly for research purposes only (RUO). Nothing here is medical, dosing, or treatment advice.

tirzepatide vs semaglutideis tirzepatide better than semaglutideSURMOUNT-5 resultsZepbound vs Wegovy weight losstirzepatide semaglutide head to headGLP-1 dual agonist comparisonincretin research comparison
Read Guide
📉
Deep Dive11 min read

Weight Regain After Stopping GLP-1s: What the Withdrawal Data Shows

Across the published withdrawal trials, stopping a GLP-1 (glucagon-like peptide-1, a gut hormone that signals satiety and slows gastric emptying) receptor agonist is followed by substantial weight regain. In the STEP 1 trial extension, participants who came off semaglutide regained roughly two-thirds of the weight they had lost within one year. In the SURMOUNT-4 trial, participants switched off tirzepatide regained on average 14% of their body weight over the same window, while those who continued the compound kept losing. The consistent signal is that the effect is pharmacological and time-limited: when the drug is removed, the appetite and metabolic changes it produced revert. This review synthesizes what the randomized discontinuation data actually report - how much weight returns, how fast, what happens to cardiometabolic markers, and whether tapering has been tested. It is written for a research and laboratory audience. The compounds discussed, including retatrutide, are supplied for research purposes only (RUO) and none of the findings below constitute medical advice or dosing guidance.

GLP-1weight regainsemaglutidetirzepatidediscontinuationSTEP-1SURMOUNT-4research review
Read Guide
📉
Deep Dive11 min read

Tirzepatide Side Effects: Rates by Dose and How Long They Last

In the published tirzepatide trials, the most frequently reported adverse events were gastrointestinal - nausea, diarrhea, constipation, and vomiting - and their incidence rose with dose. In SURMOUNT-1, the largest obesity trial, the published data reported nausea in roughly 25 to 33 percent of participants across the 5, 10, and 15 mg arms versus about 9.5 percent on placebo, with most events characterized as mild to moderate and concentrated during the dose-escalation period. This summary is for research and laboratory audiences only and describes findings from human clinical trials of an approved pharmaceutical; it is not a safety profile for any research-use-only (RUO) compound and is not medical advice. Tirzepatide is a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist. Because its receptor pharmacology overlaps with the broader incretin class - including the triple agonist retatrutide - the tirzepatide adverse-event literature is frequently examined as a reference point when characterizing incretin-related tolerability. Below we summarize what the SURMOUNT and SURPASS programs reported, how event rates tracked with dose, and, critically, what these trials cannot tell you.

tirzepatideadverse eventsgastrointestinaldose escalationSURMOUNTSURPASSGLP-1research
Read Guide
💪
Deep Dive11 min read

Does GLP-1 Weight Loss Cause Muscle Loss? What the Lean-Mass Data Shows for Semaglutide and Tirzepatide

Yes. Across the published weight-loss trials, a meaningful share of the total weight lost on GLP-1 and dual GIP/GLP-1 receptor agonists is lean mass, not fat. Body-composition substudies of semaglutide and tirzepatide, measured by DXA, have reported that roughly one quarter to two fifths of the weight lost came from lean body mass (all non-fat tissue - muscle, organ, connective tissue, and body water), a proportion broadly consistent with what is observed during rapid weight loss from any cause. This article reviews what the lean-mass data actually shows, why the number is easy to misread, and which growth-hormone-axis peptides - including tesamorelin - are being studied preclinically and clinically for the specific goal of preserving lean mass during weight reduction. Everything below is framed for research and laboratory audiences. None of it is medical or dosing advice, and these compounds are sold strictly for research purposes only (RUO).

GLP-1semaglutidetirzepatidelean massbody compositiontesamorelinsarcopeniaweight loss research
Read Guide
⚖️
Education11 min read

Is BPC-157 Legal in 2026? FDA Category 2, the PCAC Compounding Review, and RUO Status Explained

As of 2026, BPC-157 remains legal to purchase and possess in the United States as a research-use-only (RUO) compound. It is not a scheduled controlled substance under the DEA, and no federal statute criminalizes its sale for laboratory research. The regulatory activity that produced "BPC-157 ban" headlines concerns a narrow and separate question - whether licensed pharmacies may compound BPC-157 into preparations for human use - and does not change the substance's status as a research chemical. Much of the confusion online conflates three legally distinct questions: is the compound scheduled, is it an approved drug, and may it be compounded for patients. Only the third question is affected by the FDA compounding categories and the Pharmacy Compounding Advisory Committee (PCAC) review process. This article separates those questions, explains what the interim Category 2 designation actually means, and clarifies why the RUO research channel for BPC-157 and TB-500 is governed under a different part of the framework entirely.

is BPC-157 legal 2026BPC-157 FDA statusBPC-157 Category 2 compoundingPCAC compounding reviewBPC-157 RUO statusTB-500 legal status503A bulks listresearch peptide regulation
Read Guide
💊
Intermediate11 min read

Oral vs Injectable BPC-157: Does the Capsule Actually Work? A Bioavailability Breakdown

Oral and injectable BPC-157 are not interchangeable, and the published research treats them as tools for different jobs. In rodent studies, orally (intragastric) administered BPC-157 has produced measurable effects, but the strongest, most-replicated oral results are on the gastrointestinal tract itself, where the peptide makes direct contact with the target mucosa. For distal tissues such as tendon, muscle, and the vascular and central nervous systems, injectable routes (subcutaneous or intraperitoneal) are the routes the foundational literature actually used. Critically, no published human study has ever quantified the oral bioavailability of BPC-157, so any specific "capsule absorption percentage" you see quoted is not grounded in the literature. This article breaks down what bioavailability (the fraction of an administered dose that reaches systemic circulation intact and available to act) means for route selection, why BPC-157 is an unusual peptide that resists gastric degradation, and why oral research protocols use higher nominal doses than injectable ones. Everything here describes preclinical research on a compound sold strictly for research purposes only (RUO). None of it is dosing guidance or a claim of human benefit.

BPC-157 oral vs injectableoral BPC-157BPC-157 bioavailabilityBPC-157 capsuleBPC-157 subcutaneousBPC-157 administration routepeptide bioavailabilityBPC-157 research
Read Guide
🔬
Deep Dive12 min read

Does BPC-157 Cause Cancer? What the Angiogenesis and VEGF Research Actually Shows

There is no published evidence that BPC-157 causes cancer, and no genotoxicity or mutagenicity signal has been reported in the peer-reviewed preclinical literature. BPC-157 is a peptide that modulates growth-factor and nitric-oxide signaling rather than a DNA-reactive compound, so a direct carcinogenic mechanism is not biologically expected. The genuine, unresolved question is narrower and entirely theoretical: because BPC-157 promotes new blood vessel formation, and because established tumors depend on new blood vessels to grow, active cancer status is treated as the key theoretical contraindication in research framing. That caution exists not because tumor promotion has been demonstrated, but because it has not been formally ruled out in humans. This review separates the two questions that routinely get merged. First, is BPC-157 a carcinogen or mutagen (a compound that initiates cancer by damaging DNA)? The available data says no. Second, could BPC-157's pro-angiogenic activity theoretically support a tumor that already exists? That is a legitimate open question grounded in vascular biology, and it is the reason researchers flag active malignancy as an exclusion rather than treating the compound as universally benign.

BPC-157cancerangiogenesisVEGFgenotoxicitytumor biologysafetyresearch peptides
Read Guide
🔬
Deep Dive11 min read

Does Dihexa Actually Work? The 2025 Retractions and What Evidence Still Stands

Dihexa is a real, chemically characterized peptide, but the most-cited evidence for its dramatic cognitive potency has collapsed under a research-integrity scandal. In April 2025, the key 2014 paper that supplied dihexa's HGF/c-Met synaptogenesis mechanism was formally retracted, and a second foundational paper carries a Notice of Concern, after co-author Leen Kawas was found to have manipulated images in her doctoral work and related publications. No published human efficacy trial has ever validated dihexa as a cognitive compound. This article is written for research and laboratory audiences and is strictly informational. It does not recommend, dose, or endorse any use of dihexa in humans. Dihexa sold by Blackwell BioLabs is for research purposes only (RUO). The goal here is narrow and honest: separate what the literature actually established from what has been withdrawn, so researchers can weigh the compound on evidence rather than on the potency headline that made it famous.

Dihexaretractionresearch integrityHGFc-MetLeen Kawascognitivepreclinical
Read Guide
🧬
Advanced12 min read

N-Acetyl Semax Amidate vs Semax: What Acetylation and Amidation Actually Change

N-Acetyl Semax Amidate and Semax share the same core heptapeptide sequence (Met-Glu-His-Phe-Pro-Gly-Pro), but the amidate variant carries two chemical modifications at its ends: an acetyl group on the N-terminus and an amide group replacing the free carboxyl on the C-terminus. In principle these modifications block the exopeptidase enzymes that clip peptides from their ends, which is expected to slow enzymatic breakdown and lengthen the window over which the molecule stays intact. The practical claims that follow from this - longer half-life, higher apparent potency, and lower research doses - are extrapolations from peptide chemistry, not conclusions from head-to-head human trials. The critical point for any researcher comparing the two: the extensive clinical and mechanistic literature that exists for Semax was generated with unmodified Semax, the version registered as a drug in Russia. No comparable body of controlled data exists for the N-acetyl amidated analogue. This article separates what the chemistry predicts from what the evidence actually demonstrates.

N-Acetyl Semax AmidateSemaxpeptide half-lifeterminal modificationBDNFnootropic peptideenzymatic stabilitystructure-activity
Read Guide
🧪
Intermediate11 min read

SS-31 Protocol Guide: Reconstitution, Dosing Ranges, and Cycle Length in Research

In the published clinical record, SS-31 (elamipretide) was administered as 40 mg once daily by subcutaneous injection - the dose used in both the MMPOWER-2 crossover study and the pivotal Phase 3 MMPOWER-3 trial in primary mitochondrial myopathy. That single number anchors nearly every practical question a laboratory asks about reconstitution, draw volume, storage, and cycle length, because it is the only sustained human exposure the peer-reviewed literature actually documents. This guide maps that trial parameter onto the handling arithmetic a research setting faces: how to reconstitute a lyophilized vial, how injection volume changes with concentration, what the studies suggest about duration, and where the evidence runs out. SS-31 is supplied strictly for research use only (RUO). None of the numbers below are dosing guidance for humans - they are the arithmetic and the trial evidence, reported as they appear in the source material.

SS-31elamipretidereconstitutiondosingMMPOWERsubcutaneousprimary mitochondrial myopathyresearch peptides
Read Guide
🛡️
Advanced11 min read

Is SS-31 Safe? Side Effects and Tolerability Across Elamipretide Trials

Across the published elamipretide (SS-31) clinical program, the most consistently reported adverse event was injection-site reactions - localized redness, itching, and induration where the compound was administered subcutaneously - and these were generally described as mild to moderate and self-limiting. Serious adverse events attributed to the compound were uncommon in the Phase 1 and Phase 2 trials, but the total controlled human safety database remains small, short in duration, and confined to specific disease populations rather than healthy long-term users. That combination - a relatively clean short-term tolerability signal sitting on top of a thin long-term database - is the honest summary of what the literature can and cannot tell a researcher. This article walks through where SS-31 safety data actually comes from, what the trials reported, and the specific gaps that no published study has yet filled. SS-31 is sold strictly for research purposes only (RUO) and is not approved by any regulatory agency for human use.

SS-31 side effectsSS-31 safetyelamipretide adverse eventsSS-31 injection site reactionsSS-31 tolerabilityelamipretide safety profileSS-31 peptide researchmitochondrial peptide safety
Read Guide
⏱️
Advanced11 min read

MOTS-c Dosage and Half-Life: What the Research Says About Timing and Frequency

MOTS-c is a 16-amino-acid mitochondrial-derived peptide with a short circulating half-life: small unmodified peptides of its size are cleared from plasma within minutes to a few hours, and the endogenous exercise-induced spike in circulating MOTS-c returns toward baseline within hours. The downstream signaling it triggers - AMPK activation and a shift in metabolic gene expression - persists considerably longer than the peptide itself remains in the blood. That gap between how long the molecule circulates and how long its effects last is the single most important fact for interpreting every dosing-frequency and cycle-length question in the MOTS-c literature. This reference is written for research and laboratory audiences. It summarizes what the published preclinical literature reports about MOTS-c pharmacokinetics, the dosing regimens investigators have actually used in animal models, and the handling and reconstitution practices common in research settings. It is not dosing guidance, and it does not describe human use. MOTS-c is offered strictly for research purposes only (RUO). No controlled interventional human pharmacokinetic trial of exogenous MOTS-c has been published, so any statement about human half-life or human dosing frequency would be speculation, and this article does not make one.

MOTS-chalf-lifedosing frequencypharmacokineticsAMPKreconstitutionprotocolmitochondrial peptide
Read Guide
Peer-Reviewed Sources

Published References

0 sources indexed from PubMed Central

Browse PubMed Central
Quick Reference

Research Glossary

Key terms every peptide researcher should know

🔗

Peptide

A short chain of amino acids (2–50) linked by peptide bonds. Shorter than proteins, and often more bioavailable.

📈

HPLC Purity

High-Performance Liquid Chromatography - the gold standard for measuring compound purity. >98% is research-grade.

❄️

Lyophilized

Freeze-dried powder form of a peptide. Highly stable for storage; requires reconstitution before use.

💧

Reconstitution

The process of dissolving a lyophilized peptide in bacteriostatic water or another solvent for use.

⏱️

Half-life

The time required for the concentration of a compound to reduce to half its initial value in the body.

🔑

Agonist

A molecule that binds to a receptor and activates it, producing a biological response.

🩸

Angiogenesis

The formation of new blood vessels from pre-existing ones. Key mechanism in tissue repair peptides like BPC-157.

🧠

BDNF

Brain-Derived Neurotrophic Factor - a key protein for neuronal growth and survival. Upregulated by several nootropic peptides.

GLP-1

Glucagon-Like Peptide-1 - an incretin hormone. Target of metabolic peptides like Retatrutide.

📋

COA

Certificate of Analysis - document from a third-party lab confirming purity, identity, and specification of a compound.

💉

Subcutaneous

Injection into the layer of fat beneath the skin. Common route for many research peptides.

🔋

Sirtuin

A class of proteins involved in cellular regulation, DNA repair, and aging - activated by NAD+.

🧮

Peptide Calculator

Exact volumes for any compound, instantly. Enter peptide amount and desired concentration - we handle the math.